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Chapter 1 





1.1 Mesenchymal stromal cells  
 
1.1.1 Historical perspective 
 
During the 1960s, Friedenstein and co-workers observed discrete colonies of plastic adherent non-
mononuclear, fibroblast-like elongated cells in bone marrow cultures two weeks post-seeding. 
When these cells were injected underneath the renal capsule of a mouse kidney for a few weeks they 
were found to initially differentiate into fibrous tissues then to bone and finally to bone containing 
bone marrow (Friedenstein et al., 1966). In the 1970s, Wolf and Trentin described a cell culture 
model in which differentiation of hematopoietic stem cells can be induced by a spleen or bone 
marrow microenvironment (Trintin et al., 1989). In 1971, Dexter and colleagues found that long-
term maintenance of mouse hematopoietic cells in in vitro cultures depended on the presence of 
adherent stromal cells in the culture system as well as a direct contact between hematopoietic stem 
cells and these stromal cells (Dexter et al., 1977). During the 1980s and 1990s, researchers found 
that the tissue-forming cells described by Friedenstein were multipotent cells that are capable of 
differentiating into osteoblasts, chondroblasts and adipocytes. In 1999, Mark Pittenger observed 
these multipotent cells in human bone marrow cells and later on developed techniques to identify 
these cells by their ability to express certain antigens. In 2008, these multipotent cells were found 
to be different from endothelial and hematopoietic cells (Delorme et al., 2008). Arnold Caplan was 
the first to name these cells mesenchymal stem cells (Caplan et al., 1991). Initially they were called 
osteogenic differentiation cells by Friedenstein or marrow stromal cells by Maureen Owen, while 
Paolo Bianco and Pamela Robey called the cells skeletal stem cells because of their ability to give 
rise to cellular components of the skeleton (Bianco et al., 2008). James Dennis suggested that these 
cells should be called mesenchymal progenitor cells, saying they are bonafide stem cells (Dennis et 
al., 1999). Finally, the international society for cellular therapy proposed the name multipotent 
mesenchymal stromal cells (Horwitz et al., 2005), which can be differentiated into many cell types 
including osteoblast, adipocytes and chondrocytes and expanded in vitro.  
Unlike hematopoietic stem cells that were identified at different stages of differentiation using 
antibodies directed against certain cell surface markers, the mesenchymal stromal cell identification 




cell surface marker is expressed by mesenchymal stromal cells, which can differentiate into 
chondrocytes, adipocytes and osteocytes and also support the proliferation and survival of 
hematopoietic cells (Gronthos et al., 1994). Using FACS, mesenchymal stromal cells were separated 
from other bone marrow cells by their high expression of STRO-1 (Jones et al., 2006), which shed 
more light on the heterogeneity of bone marrow cell populations. When further analyzed, bone 
marrow STRO-1hi cells were found to be negative for typical hematopoietic cells markers, such as 
CD34, CD14, CD45 and CD11b. STRO-1hi cells also lack the expression of endothelial cell markers, 
such as von Willebrand factor (VWF). Also during the time STRO-1 monoclonal antibodies were 
developed, the monoclonal antibodies SH-2 (CD105), SH-3 and SH-4 (CD73) were produced by 
Caplan. These mAbs detected antigens on the surface of red bone marrow mesenchymal cells, but 
not on red bone marrow hematopoietic cells. This allowed the proper classification of bone marrow 
mesenchymal stromal cells (Hayensworth et al., 1992). Other markers such as THY-1 (CD90), 
which were first identified on mice T-cells, were also found to be highly expressed by fibroblast in 
the hematopoietic tissues (Raff et al., 1971). It was recently recognized as a good marker for 
mesenchymal cell enrichment (Delorme et al., 2008). Furthermore, adhesion molecules, such as 
CD106 (VCAM-1; vascular cell adhesion molecule) and CD166 (ALCAM; activated leukocyte cell 
adhesion molecule), which belong to immunoglobulin-domain members of cell adhesion molecules, 
were also found to be expressed by mesenchymal stromal cells. Finally, in 2006 the International 
Society of Cellular Therapy set up a minimum of criteria for identifying mesenchymal stromal cells, 
based on (i) their ability to adhere to cell culture plastic, (ii) expression of specific surface antigens: 
CD73, CD90, CD44, CD105 and CD55, (iii) absence of CD14, CD11b and CD45, (iv) ability to 
differentiate into osteocytes, chondrocytes and adipocytes. Initially, bone marrow was the main 
source of mesenchymal stromal cells, but later it was also derived from adipose tissues, lung tissues, 
spleen, lymph nodes, umbilical blood and peripheral blood.   
 
1.1.2 Multilineage differentiation 
 
Mesenchymal stromal cells are defined by their ability to differentiate into many cell types including 
osteocytes, chondrocytes and adipocytes. The following paragraphs describe how to trigger 






1.1.2.1 Osteogenic differentiation 
 
Osteogenic differentiation of bone marrow mesenchymal stromal cells into osteoclasts is controlled 
by systemic hormones, such as parathyroid hormone, estrogen or glucocorticoids or by local growth 
factors belonging to the bone morphogenetic protein (BMP) family, transforming growth factor-
beta (TGF-β) and fibroblast growth factor-2 (FGF-2). These factors trigger the activation of specific 
signaling pathways within the mesenchymal stromal cells causing the modification of several 
transcription factors leading to differentiation of the cells into osteocytes and not chondrocytes or 
adipocytes. The major transcription factor responsible for the differentiation of mesenchymal 
stromal cells into osteocytes is Runt-related transcription factor 2 (Runx-2) (Gaur et al., 2005). 
Differentiation of mesenchymal stromal cells into osteoclasts in in vitro cultures is performed in the 
presence of dexamethasone, ascorbic acid and β-glycerol phosphate (Jaiswal et al., 1997). These 
reagents work at different time points inducing and maintaining osteogenesis. It has been reported 
that dexamethasone induces the differentiation of mesenchymal stromal cells into both osteocytes 
and adipocytes. When mesenchymal stromal cells start to differentiate into osteocytes, their 
morphology changes from spindle-shaped to cuboidal-shaped and mineralization can be observed 
on the cell membrane with generalized deposition of calcium. The calcium deposit can be 
demonstrated on the differentiated mesenchymal stromal cells by staining the cells with a solution 
of alizarin red (see Fig 1). 
 
1.1.2.2 Chondrogenic differentiation 
 
Differentiation of mesenchymal stromal cells from different sources (bone marrow, adipose tissue, 
lungs, spleen and umbilical cord) into chondrocytes has been reported (Studer et al., 2012; 
Barrilleaux et al., 2006). Fibroblast growth factor 2 (FGF-2) plays an important role in the 
proliferation and differentiation of mesenchymal stromal cells into chondrocytes (Sakaguchi et al., 
2005). Moreover, it has been reported that serum-free medium enhances the differentiation of 
mesenchymal stromal cells into chondrocytes (Auletta et al., 2011). In vitro, chondrogenic 
differentiation of bone marrow mesenchymal stromal cells has been studied widely in micromass 
pellet condition. The initial phase of chondrogenic differentiation of mesenchymal stromal cells 




interactions. Next, the growth rate increases and the cells start to produce collagen type II, collagen 
type IX, collagen oligometric matrix protein and matrilin. Finally, the cells take the morphology of 

















Fig 1: Schematic representation of mesenchymal stromal cell differentiation into chondrocytes, adipocytes and 
osteocytes. CD105+, CD90+, CD29+ and CD44+ mesenchymal cells are differentiated into chondrocytes by BMPs, FGF-
2, Wnt, SOX5, SOX6 and SOX9, into adipocytes by PPAR-γ, PDGF and C/EBPα, and into osteocytes by BMPs, FGF-
2, RUNX-2 and TGF-β. Chondrogenic, adipogenic and osteogenic differentiation of the mesenchymal cells are achieved 
by incubating the mesenchymal cells in chondrogenic, adipogenic and osteogenic differentiation medium for 21 days, 
7-14 days and 14 days, respectively, and confirmed by staining with alcian blue, oil red O and alizarin red solution, 
respectively 
 
Reports indicated that chondrogenic differentiation stages are regulated by BMPs, FGF-2, TGF-β 
and Wnt (Yang et al., 2006; Itoh et al., 2008; Leung et al., 2011; Torreggiani et al., 2012). Major 
transcription factors controlling stemness properties of cells and chondrogenic differentiation of 
mesenchymal stromal cells include SOX9, SOX5, SOX6 and Slug (Leung et al., 2011; Torreggiani 







1.1.2.3 Adipogenic differentiation 
 
Differentiation of mesenchymal stromal cells into adipocytes is performed in medium supplemented 
with indomethacin, dexamethasone, isobutylmethylxanthine and insulin. Successful differentiation 
of mesenchymal stromal cells into adipocytes is confirmed by Oil red O staining which reveals an 
oil droplet in the cytoplasm of differentiated mesenchymal stromal cells. The initial phase in the 
differentiation of mesenchymal stromal cells into adipocytes is transformation of mesenchymal 
stromal cells to pre-adipocytes; these cells have the same morphology as the mesenchymal stromal 
cells. The final phase is the maturation and full differentiation of the mesenchymal stromal cells into 
adipocytes. These cells are characterized by an expanded lumen and accumulation of fat droplets in 
the cytoplasmic space. The adipogenic environment stimulates the activation of ERK1 and ERK2 
in the initial phase of the adipogenic differentiation. ERK1 and ERK2 trigger the expression of the 
transcription factors PPAR-γ and C/EBPα, which are crucial in the terminal stages of adipogenic 
differentiation of mesenchymal stromal cells (Prusty et al., 2002). In addition to dexamethasone, 
ascorbic acid and β-glycerolphosphate are used to stimulate adipogenic differentiation of 
mesenchymal stromal cells in in vitro cultures; 1-methyl-3-isobutylxanthine (MIX) or 3-isobutyl-1-
methylxanthine (IBMX) are used to enhance adipogenic differentiation of mesenchymal stromal 
cells (Yeh et al., 1995) (see Fig 1). 
  
1.1.3 Mesenchymal stromal cells support the viability and proliferation of hematopoietic 
cells 
 
Hematopoietic cells are pluripotent cells capable of life-long replenishment of the hematopoietic 
microenvironment with hematopoietic progenitors and all mature blood cells (Zon et al., 2005). A 
balance is always maintained between the differentiation of hematopoietic cells into specific blood 
cell lineages and proliferation of undifferentiated hematopoietic cells. Mature white blood cells are 
typically divided into two separate lineages: the lymphoid and the myeloid lineage. The myeloid 
lineage includes cells that are morphologically, functionally and phenotypically distinct. The 
myeloid cell lineage includes granulocytes (neutrophils, eosinophils, basophils) and monocytes. The 
lymphoid cell lineage comprises T-lymphocytes, B-lymphocytes and natural killer cells. Another 




lymphoid lineage cells are dendritic cells (Manz et al., 2001; Traver et al., 2000). Common 
lymphoid progenitor cells, that can give rise to all lymphoid but not myeloid cell types, and common 
myeloid progenitor cells that can give rise to all myeloid but not lymphoid cell types, were already 
successfully isolated and extensively studied (Akashi et al., 2000). In mice, the hematopoiesis takes 
place in a small fraction of the bone marrow. These cells do not express lineage-associated markers 
(Lin), but are Sca-1 and c-Kit positive (Ikuta and Weissman, 1992). Supporting cells (stromal cells) 
present in the bone marrow participate in the initiation and maintenance of hematopoiesis.  
The mechanism regulating the self-renewal and plasticity of hematopoietic cells is not well 
understood.  However, it has been reported that both intrinsic and environmental cues play an 
important role in the homeostasis. The hematopoietic microenvironment has been studied in vitro 
by long-term culturing of bone marrow hematopoietic cells on top of stromal cells, in which the 
survival and proliferation of hematopoietic cells was observed. Stromal cells play a very important 
role in the survival, maintenance and differentiation of hematopoietic cells through intimate contact 
with the hematopoietic microenvironment components and through the secretion of cytokines, such 
as IL-6 and granulocyte macrophage colony stimulating factor (Majumdar et al., 1998; Mbalavielle 
et al., 1999).  
 
1.1.4 Immunomodulatory effect of mesenchymal stromal cells 
 
Mesenchymal stromal cells have been found to regulate the immune system modulating immune 
cell responses in many diseases. Mesenchymal stromal cells have been reported to enhance the 
survival of lymphocytes, but suppress their proliferation, cytotoxicity and cytokine secretion (Yanez 
et al., 2006; Glennie et al., 2005). Moreover, these cells inhibit the secretion of antibodies and co-
stimulatory factor by B-cells and the maturation, activation and antigen presentation of dendritic 
cells. They also inhibit the activation of IL-2 induced NK cells (Spaggiari et al., 2006). There are 
reports suggesting that mesenchymal stromal cells exert a variable immunomodulatory effect on the 
same immune cells depending on the microenvironment or disease conditions. For instance, 
mesenchymal stromal cells trigger a decrease in type 1 T helper (Th1) cells in patients with acute 
graft versus host disease and in patients with an autoimmune disease, such as systemic lupus 
erythematosus (Le Blanc et al., 2004; Rafei et al., 2009). Another example is the shift from Th2 to 





mesenchymal stromal cells. Moreover, an inflammatory condition can also improve cell-cell contact 
leading to an enhanced immunomodulatory response of mesenchymal stromal cells. Mesenchymal 
stromal cells not only exert their immunomodulatory effect through a contact-dependent mechanism 
with immune cells, but also through secretions of soluble factors that may affect immune cells. 
 
1.1.4.1 Immunomodulatory effect of mesenchymal stromal cells through the secretion of soluble 
factors 
 
Several cytokines and other soluble factors expressed by mesenchymal stromal cells have been 
reported to modulate immune cells, such as hepatocyte growth factor (HGF), transforming growth 
factor-β1 (TGF-β1), prostaglandin E2 (PGE2), indoleamine-pyrrole 2,3 dioxygenase (IDO), nitric 
oxide (NO) and interleukin-10 (IL-10). It was observed that some pro-inflammatory cytokines, such 
as interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α), trigger the secretion of some soluble 
factors by mesenchymal stromal cells, such as IDO, prostaglandin E2 (PGE2) and cyclooxygenase 
2 (COX-2), leading to suppression of immune cells (Krampela et al., 2006; Ryan et al., 2007). 
Mesenchymal stromal cell secretion of PGE2 was found to suppress T-lymphocyte proliferation, 
while IDO and NO were found to inhibit both proliferation and function of T-lymphocytes. In 
addition, IDO also induces allograft tolerance in kidneys (Jarvinen et al., 2008; Ge et al., 2010). 
Bone marrow-derived mesenchymal stromal cells were observed to upregulate the secretion of 
inducible nitric oxide synthase (iNOS; which helps to attenuate a delayed type hypersensitivity 
reaction) and some chemokines in response to IFN-γ activation. Mesenchymal stromal cells have 
also been reported to suppress allergic responses in mouse models through the secretion of TNF-β 
(Ren et al., 2008). Other soluble factors, such as galectins, IL-6 and leukemia inhibitory factors, 
were found to regulate the mesenchymal cell immunomodulatory effect (Najar et al., 2010). The 
exact mechanism used by many other soluble factors and cytokines in the immunomodulatory effect 
of mesenchymal stromal cells is not well understood. 
 
1.1.4.2 Immunomodulatory effect of mesenchymal stromal cells by cell-cell contact 
 
Many reports indicated that mesenchymal stromal cells modulate immune cells through cell-cell 




decrease the survival and proliferation of T-lymphocytes and increase the proportion of Tregs via a 
cell-cell contact dependent mechanism (Han et al., 2011). IFN-γ-mediated activation of 
mesenchymal stromal cells could result in the upregulation of adhesive molecules, such as CD44, 
CD274 and vascular cell adhesive molecule-1, and galectin-1 secretion that support cell-cell contact 
leading to an enhancement of the immunomodulatory effect of mesenchymal stromal cells (Raicevic 
et al., 2015; Ren et al., 2015). 
 
1.1.5 Mesenchymal stromal cells in (pre)clinical studies   
 
The easy isolation and cultivation, ability to differentiate into fat, bone and cartilage and good in 
vitro expansion capacity of mesenchymal stromal cells from different sources led to their use in 
clinical trials in the treatment of diseases such as diabetes and graft-versus-host diseases (GvHD). 
For instance, mesenchymal stromal cells function in the modulation and suppression of immune 
cells allowing them to reduce GvHD thereby making them useful in auto- and allogeneic cell 
therapy. Mesenchymal stromal cells are recently widely used in clinical trials to study inflammatory 
and immune disorders. An example of such a trial is the systemic administration of mesenchymal 
stromal cells to decrease allergen-specific IgE and the Th2-associated cytokines IL-4, IL-5 and IL-
13 in bronchial airways, inhibiting respiratory inflammation in mice with chronic or severe asthma 
(Firinci et al., 2011; Lee et al., 2011). Mesenchymal stromal cells are found to suppress T-
lymphocyte proliferation, inflammatory infiltrates and cytokine expression in experimental models 
leading to proctitis, colitis, immune thrombocytopenia and autoimmune encephalomyelitis. They 
were reported to have a great autoimmune suppression effect in an animal model for arthritis. 
Human mesenchymal stromal cells derived from bone marrow and umbilical cord successfully 
helped in reconstructing the bone marrow osteoblastic niche and in reversing multi-organ 
dysfunction. Researchers suggested the use of mesenchymal stromal cells in the treatment of some 
autoimmune diseases, such as thyroiditis, myasthenia gravis and hearing loss (Zhou et al., 2011; Yu 









1.1.6 Mesenchymal stromal cell senescence 
 
Large numbers of mesenchymal stromal cells are sometimes needed for large-scale reconstruction 
of specific tissues or organs in vitro. Mesenchymal stromal cell cultures for long-term research are 
also needed. Therefore, to have large numbers of mesenchymal stromal cells for large-scale 
construction of tissues or organs, the cells need to be passaged many times in in vitro cultures. 
However, the growth rate of mesenchymal stromal cells slows down after several passages. The 
cells flatten and adhere more firmly to the culture plates and sometimes lose their phenotypic 
characteristics and differentiation potential and finally die (Wagner et al., 2008). This phenomenon 
is referred to as replicative senescence. It is defined as an irreversible state of the cell cycle arrest. 
During every round of DNA replication, each eukaryotic chromosome becomes shorter at the 
telomeres because of end-replication errors by the DNA polymerase. Telomerase can elongate the 
telomeres. Because there is no telomerase activity detected in mesenchymal stromal cells, the 
telomeres shorten during proliferation. The best way to extend the life span of mesenchymal stromal 
cells is to immortalize them. Researchers successfully immortalized different cell types (endothelial 
cells, epithelial cells, mesenchymal stromal cells and fibroblasts) from different sources using 
different methods, including viral vectors expressing the large T antigen of SV40 (Jha et al., 1998; 
Kirchhoff et al., 2004) and human telomerase reverse transcriptase (htert) (Ramirez et al., 2004; 




















A pig disease characterized by late term abortion, early farrowing, stillbirth and respiratory problems 
was reported in the US (Keffaber et al., 1989), Canada (Bilodeau et al., 1991), Europe (Baron et al., 
1992) and Asia (Kuwahara et al., 1994) in the late 1980s. Due to the lack of knowledge about the 
disease, many names were assigned to it, including `Mystery swine disease´ (MSD) (Wensvoort et 
al., 1991), blue-eared pig disease (Wensvoort et al., 1991), porcine epidemic abortion and 
respiratory syndrome (PEARS) (Terpstra et al., 1991), swine infertility and respiratory syndrome 
(SIRS) (Benfield et al., 1992) and porcine respiratory and reproductive syndrome (PRRS) (Ahl et 
al., 1992). All these names reflect the symptoms of the disease. The infectious agent causing these 
symptoms was first isolated in 1991 from MSD-affected pigs by a group of researchers at ID-DLO 
in Lelystad, the Netherlands, (Wensvoort et al., 1991). This infectious agent was later characterized 
and designated as ̀ Lelystad virus` the causative agent of MSD. At around the same time, researchers 
in the US were able to culture and isolate an American isolate on CL2621 cells, which they later 
named VR-2332 (Collins et al., 1992). During the first international symposium on this disease 
‘porcine reproductive and respiratory syndrome’ (PRRS) and ‘PRRS virus (PRRSV)’ was accepted 
as the official name of the disease and the virus, respectively. PRRSV is endemic in swine producing 
countries worldwide despite a lot of efforts by farmers, veterinarians, researchers and vaccine 
developers to control the disease. Two PRRSV genotypes have been identified using phylogenetic 
analysis: the European genotype (type 1), with LV as prototype virus, and the American genotype 
(type 2), with VR-2332 as prototype (Nelsen et al., 1999). Type 1 strains of PRRSV are further 
subdivided into subtype 1, 2, 3 and 4 (Stadejek et al., 2008). Although these two genotypes differ 
significantly from one another they are thought to originate from a common ancestor. Originally, 
genotype 1 was only detected in Europe whereas genotype 2 was restricted to America and Asia. At 
present, this restriction no longer exists, because both genotype 1 and 2 PRRSV variants are found 
in Europe, America and Asia (Murtaugh et al 2010; Shi et al., 2010). Due to a high mutation rate, 
PRRSV shows a large variation in virulence, pathogenicity and antigenicity. Some of the isolates 







1.2.2 Taxonomy of PRRSV  
 
PRRSV is classified in the order of the Nidovirales, family of the Arteriviridae, genus porartevirus 
(Snijder et al., 1998). Similarities in the genome organization and the relatedness of the proteins 
involved in RNA replication and transcription are the reasons why viruses are classified within the 
Nidovirales order. The term ´´nidus´´ is a latin word which means ´´nest´´ referring to the nested 3´ 
co-terminal subgenomic-length mRNAs that are generated for expression of the open reading frames 
(ORFs) downstream of the replicase gene. Beside PRRSV, the Arteriviridae family consists of three 
other members: equine arteritis virus (EAV), simian hemorrhagic fever virus (SHFV) and lactate 
dehydrogenase-elevating virus (LDV). Arteriviruses are highly specific in their animal species 
targeting and may persist in their respective hosts. They have a similar particle morphology, genome 
organization and replication strategy. Cryo-electron microscopy showed that the particles are 
spherical ranging from 50 to 70 nm in diameter with a small projection on their surface (Snijder et 
al., 1998). This enveloped positive-stranded RNA group of viruses primarily targets macrophages 
and endothelial cells.  PRRSV has the ability to rapidly evolve, allowing it to undergo huge genetic 
and antigenic changes over time. This genetic and antigenic variation allows PRRSV to exist in a 
single individual animal as a cluster of different virus variants. Researchers suggested that PRRSV 
may exist as a quasispecies as after each round of replication a mixture of virions having different 
closely related genomes is present. 
 
1.2.3 Genome organization and virion structure 
 
1.2.3.1 Genome organization 
 
The genome of PRRSV is a positive-sense, single-stranded RNA approximately 15.1 kb for the 
European strain and 15.4 kb for the north American strain (Meulenberg et al., 1997). The genome 
contains many ORFs with capped 5´ terminal end and polyadenylated 3´ terminal end (Johnson et 
al., 2011). The 5´ terminal end consists of ORF1a and ORF1b which occupy about 70-80% of the 
total genome length of PRRSV (Fang et al., 2010). Two large polyproteins pp1a and pp1ab which 




by the so called ´replicase ORFs´ (Brierley et al., 1995; den Boon et al., 1991). These non-structural 
proteins are required for PRRSV genome replication and subgenomic mRNA production. Many 
smaller, overlapping ORFs (ORF2a, ORF2b, ORF3, ORF4, ORF5, ORF6 and ORF7) are involved 
in encoding the structural proteins (GP2, E, GP3, GP4, GP5, M and N, respectively) and are located 
at the 3´ terminal end region of the PRRSV genome (Wu et al., 2001; Meulenberg et al., 1996; 
Meulenberg et al., 1995; Music et al., 2010) (see Fig 3).  
 
1.2.3.2 Virion structure 
 
The PRRSV particle consists of an icosahedral nuclear capsid containing the RNA viral genome 
surrounded by a lipid bilayer of a smooth spherical envelope (Dockland et al., 2010; Dea et al., 
1995; Mardassi et al., 1994; Wensvoort et al., 1992; Spilman et al., 2009). The nucleocapsid is 
composed of nucleocapsid proteins (N) that are highly basic and predominantly disulfide-linked 
homodimers (Mardassi et al., 1996; Wootton et al., 2003). The higher organized structure of the 
PRRSV nucleocapsid is probably due to a non-covalent association of nucleocapsid proteins (N) 
(Wootton et al., 2003). The other PRRSV structural proteins are virion membrane proteins found 
enclosed in the envelop of the virion. These proteins are the small envelop protein E, the membrane 
protein M and the N-glycosylated glycoproteins GP2, GP3, GP4, GP5 (Mardassi et al., 1996). A 
PRRSV structural protein ORF5a was identified by Jonson et al. (2001) and is assumed to be a 
membrane protein. Moreover, PRRSV major structural proteins include M, N and GP5 proteins, 
while the minor structural proteins of PRRSV are GP2, E, GP3, GP4 (Mardassi et al., 1996). The GP5 
and M proteins are present in the virion as covalently linked heterodimers because of the disulfide-
bonds formed between the ectodomains of these proteins (Dockland et al., 2010) (see Fig 2).  
 
1.2.4 Cell tropism 
 
Similar to other members of the Arteriviridae family, PRRSV has a tropism for cells of the 
monocyte∕macrophage lineage. PRRSV mainly targets and infects subsets of differentiated 
macrophages residing in the lymphoid tissues, lungs and placenta. Macrophages originate from 





















Fig 2: PRRSV virion structure and morphology. 
Schematic overview of PRRSV virion structure. The virus particle is made up of a nucleocapsid, which is surrounded 
by an envelope. The nucleocapsid consists of a viral genome and nucleocapsid proteins. Small envelop protein E, 
membrane protein M and N-glycosylated glycoproteins GP2, GP3, GP4 and GP5 are found within the viral envelope.  
Adapted with the permission of Wander Van Breedam. 
 
These macrophages have a self-renewal ability. During infection, monocytes are attracted to the 
infected tissues and depending on the local microenvironment may differentiate into new 
macrophages. These differentiated macrophages are particularly CD163 and sialoadhesin positive 
cells. Blood monocytes are not susceptible to PRRSV (Duan et al., 1997; Teifke et al., 2001; Duan 
et al., 1998). Many cell types are used for cultivating and propagation of PRRSV in in vitro studies. 
Primary cultures of porcine alveolar macrophages are widely used to produce the virus because they 
are the main target of PRRS in vivo. The African green monkey kidney cell line MA-104 or cells 
derived from this cell line are also used to grow some strains (Kim et al., 1993; Mengeling et al., 
1995). 
 
1.2.5 Replication cycle 
 
The ability of PRRSV to successfully enter into its target cell depends on the presence or absence 
of specific entry mediators (Kreutz et al., 1998). Several cell mediators are reported to be involved 
in PRRSV entry into its target cells. Heparan sulphate was identified in the 1990s. In 1997, Jusa et 
al. reported the possible use of heparin-like molecules on the surface of Mark-145 cells by PRRSV 




heparin, and later with the virus; this led to a significant decrease in the infection of the cells by 
PRRSV. Similar results were obtained by incubating the cells with heparinase I, an enzyme 
responsible for cleaving heparin and heparin sulphate (Delputte et al., 2002). When the same 
experiments were performed with porcine alveolar macrophages similar results were obtained 
(Delputte et al., 2002). Sialoadhesin, also called CD169 or siglec-1, is a member of the sialic acid 
binding lectin family, called siglecs. This protein is found to be expressed only on differentiated 
macrophages and is involved in the attachment and internalization processes of PRRSV (Duan et 
al., 1998; Duan et al., 1997). Two mAbs 41D3 and 41D5, recognizing sialoadhesin, were generated 
by Duan et al. in 1998. It was found that incubating PRRSV susceptible cells with 41D3 and 41D5 
mAbs prevented the attachment of PRRSV to the cells, thereby blocking PRRSV infection. CD163, 
a type I transmembrane glycoprotein and scavenger receptor is found to be expressed only by cells 
of the monocyte∕macrophage lineage (Sanchez et al., 1999; Van den Heuvel et al., 1999). Blocking 
CD163 by incubating macrophages with CD163-specific mAbs clearly reduced PRRSV infection 
(Van Gorp et al., 2008). While siglec-1 and CD163 have been identified as the most important entry 
mediators for PRRSV (Van Gorp et al., 2008; Duan et al., 1998; Duan et al., 1997), recent research 
demonstrated that PRRSV also show a tropism for siglec-10, that can replace siglec-1 as receptor 
mediating PRRSV binding and internalization (Frydas et al., 2013; Xie et al., 2017). Other entry 
mediators used by PRRSV for entry into the cells are cellular proteases, such as the aspartic acid 
protease cathepsin E (Misinzo et al., 2008). 
Unstable binding of the PRRSV sugars with specific cell entry mediators on the surface of the target 
cell is the first stage in the infection process. The M/GP5 complex interacts with heparin sulphate 
moieties on glycoproteins present on the membrane of the target cells. This weak PRRSV-cell 
interaction allows the virus to glide on the macrophage surface until it is able to locate its specific 
receptor sialoadhesin (siglec-1), which mediates the internalization of the virus into the macrophage. 
Immediately after internalization, PRRSV releases its genome into the cytoplasm of the host cell 
followed by translation of the ORF1a and ORF1b genes encoding the nonstructural proteins pp1a 
and pp1ab (Fang et al., 2010; Pasternak et al., 2006). These two polyproteins undergo extensive 
proteolytic processes. The pp1a polyprotein is cleaved 9 times by specific proteases producing 10 
different nonstructural proteins, while pp1ab is cleaved 3 times yielding 13 nonstructural proteins 
(Fang et al., 2010). A combination of PRRSV RNA-dependent RNA polymerase, RNA helicase, 





together to form a viral transcription and membrane-associate replication complex that is involved 
in the replication of the viral genome and synthesis of the nested subgenomic mRNAs (Fang et al., 
2010; Pasternak et al., 2006). Full-length minus strand RNA is synthesized from positive sense 
genomic RNA in the membrane-associated replication complex. This RNA is used as a template for 
the synthesis of genomic RNA (Fang et al., 2010; Pasternak et al., 2006). Many polycistronic 
subgenomic minus strand RNAs with an identical 3´ and 5´ end terminal leader sequence are 
generated from the 5´ end terminal region of this genome. These RNAs are used for encoding 
different structural viral proteins. The GP2 and E protein are translated from mRNA2 which is 
functionally bicistronic, while ORF5a and GP5 proteins are translated from mRNA5. The mRNA3, 
4, 5, 6 and 7 are used to generate GP3, GP4, GP5, N and M proteins, respectively (Fang et al., 2010; 
Pasternak et al., 2006). After synthesis, all the structural proteins, except nucleocapsid protein N, 
integrate into the membrane of the endoplasmic reticulum (ER). In the ER, N-linked glycans are 
added to GP2, GP3, GP4 and GP5 proteins with the formation of intra- and inter-disulphide bridges 
in and between the viral envelope. The nucleocapsid protein in the cytosol interacts with the newly 
synthesized viral genomic RNA strand to form new viral cores. Budding of these virion cores into 
the lumen of the ER allows them to obtain an envelope containing viral envelop proteins (Faaberg 
et al., 2008). For the immature virus to become mature it subsequently travels through the lumen of 
the ER and Golgi apparatus, where the N-linked glycans on the surface of the viral particles undergo 
further modifications. Finally, the new virus particles are released from the host cell by exocytosis 
(Faaberg et al., 2008) (see Fig 3). 
 
1.2.6 Pathogenesis of PRRSV 
 
The transmission of the virus between infected and non-infected pigs in the herd is through close 
contact like nose-nose contact or by contact with nasal discharge, faeces and urine. PRRSV can be 
introduced into a PRRSV-free herd by bringing into the herd infected animals or contaminated 
fomites like boots, clothes and equipment (Rossow et al., 1998). PRRSV can also be transmitted to 
non-infected pigs by infected pigs via aerosol. PRRSV can travel as an aerosol for up to 9 km. This 
can be facilitated by low temperature, high humidity and low wind speed (Komijn et al., 1991) and 
is correlated with the pathogenicity of the isolate (Otake et al., 2002). In addition, PRRSV spreading 




Naturally PRRSV infection begins mainly through inhalation, ingestion and coitus. Experimental 
infection of pigs with PRRSV can be achieved via intratracheal, intranasal, intramuscular, 
intravenous, oronasal and intraperitoneal inoculation. Macrophages are the main target of the virus 
in vivo. Especially macrophages from lungs, tonsils, lymph nodes and spleen are very susceptible 
to the virus. PRRSV infection starts in the macrophages residing at the site of virus uptake and in 
the draining lymph nodes (Rossow et al., 1998). PRRSV can be detected in the blood 12 h to 3 days 
after infection and persist in the blood for up to 6 weeks after the initial infection with the highest 
virus titer in the blood between 5 and 14 days after infection. From the blood the virus is able to 
spread to macrophage subsets in different organs of the body. PRRSV is also found in testicles of 
infected boars and placenta of pregnant sows, where the virus is capable of crossing the placenta to 
infect the fetus. This occurs during the third trimester of gestation. It has been reported that PRRSV 
infected pigs can naturally recover from the disease within 2 to 4 months (Rossow et al., 1998). 
 
1.2.7 PRRSV control 
 
Despite many challenges such as genetic variation, vaccination is the most widely used method of 
preventing and controlling PRRSV infections in pigs (Charerntantanakul et al., 2012). But PRRSV 
control requires much more than vaccination. A systemic approach to PRRS management is 
necessary to achieve a long-term success. This includes controlling PRRS in breeding herd using 
for instance the Load-Close-Expose protocol which stabilizes the PRRSV status in a breeding herd 
before introducing new PRRSV-negative animals. PRRSV can also be controlled by a full depop-
repop program (Perez, AM., et al 2015; Corzo, CA., et al., 2010). More recently, researchers started 
































Fig 3: Schematic presentation of PRRSV replication cycle in the host cells. 
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2.1 Aims of the thesis 
 
Mesenchymal stromal cells have been successfully isolated from red bone marrow and several other 
tissues. These cells can differentiate into many cell types such as chondrocytes, adipocytes and 
osteocytes. Due to their multi-lineage differentiation capabilities and strong immunomodulatory 
effect on different types of both innate and adaptive immune cells, mesenchymal cells received 
considerable attention from researchers as cells with great therapeutic potential. The anti-
inflammatory and immunomodulatory effects of mesenchymal stromal cells have been explored for 
their potential use in the treatment of diseases such as graft-versus-host disease and diabetes. 
However, keeping mesenchymal stromal cells and their continuous passaging in in vitro cultures for 
a long time is a major challenge because they undergo senescence and die. Therefore, there is an 
urgent need for establishing continuous mesenchymal stromal cell cultures for studying 
mesenchymal-immune cell interactions. The development of an in vitro model for co-culturing 
immortalized mesenchymal stromal cells with bone marrow- and blood-derived immune cells will 
help to better understand mesenchymal-immune cell interactions for therapeutic applications and 
the effect of mesenchymal stromal cells on host-pathogens interactions, such as PRRSV replication 
in monocytes/macrophages, easing the way for finding possible treatments for infectious and non-
infectious diseases. 
The specific aims of this thesis are: 
 To develop a long-term co-culture system for maintenance and differentiation of 
hematopoietic cells on top of immortalized mesenchymal stromal cells towards the 
monocyte/macrophages lineage. 
 To establish mesenchymal stromal cell lines from different tissues of pigs for long-term 
studies such as the differentiation of blood-derived monocytes to siglec-1 expressing 
macrophages. 
 To explore the effect of mesenchymal cells on pathogen-macrophage interactions by 
examining the replication kinetics of porcine reproductive respiratory syndrome virus in 
macrophages co-cultured with immortalized mesenchymal stromal cell
                                                    
 
Chapter 3 
Long-term culture and differentiation of porcine 
red bone marrow hematopoietic cells  
co-cultured with immortalized  





Abubakar Garba, Lowiese M.B. Desmarets, Delphine D. Acar, Inge D.M. Roukaerts, 
Bert Devriendt and Hans J. Nauwynck 
 







Mesenchymal stromal cells are multipotent stromal cells with self-renewal, differentiation and 
immunomodulatory capabilities. We aimed to develop a co-culture model for differentiating 
hematopoietic cells on top of immortalized mesenchymal stromal cells for studying interactions 
between hematopoietic and mesenchymal stromal cells, useful for adequately exploring the 
therapeutic potential of mesenchymal stromal cells.  In this study, we investigated the survival, 
proliferation and differentiation of porcine red bone marrow hematopoietic cells co-cultured with 
immortalized porcine bone marrow mesenchymal stromal cells for a period of five weeks. Directly 
after collection, primary porcine bone marrow mesenchymal stromal cells adhered firmly to the 
bottom of the culture plates and showed a fibroblast-like appearance, one week after isolation. Upon 
immortalization, porcine bone marrow mesenchymal stromal cells were continuously proliferating. 
They were positive for simian virus 40 (SV40) large T antigen and the mesenchymal stromal cell 
markers CD44 and CD55. Isolated red bone marrow cells were added to these immortalized 
mesenchymal stromal cells. Five weeks post-seeding, 92±6% of the red bone marrow hematopoietic 
cells were still alive and their number increased 3-fold during five weekly subpassages on top of the 
immortalized mesenchymal stromal cells. The red bone marrow hematopoietic cells were originally 
small and round; later, the cells increased in size. Some of them became elongated, while others 
remained round. Tiny dendrites appeared attaching hematopoietic cells to the underlying 
immortalized mesenchymal stromal cells. Furthermore, weekly differential-quick staining of the 
cells indicated the presence of monoblasts, monocytes, macrophages and lymphocytes in the co-
cultures. At three weeks of co-culture flow cytometry analysis showed an increased surface 
expression of CD172a, CD14, CD163, CD169, CD4 and CD8 up to 37±0.8%, 40±8%, 41±4%, 
24±2%, 19±5% and 24±3% of the hematopoietic cells, respectively. In conclusion, continuous 
mesenchymal stromal cell cultures were successfully established and characterized and they 
supported the proliferation of red bone marrow hematopoietic cells, which finally differentiated into 










The red bone marrow serves as the main source of white blood cells in mammals. Red bone marrow 
consists of two main cell types, the hematopoietic cells and non-hematopoietic stromal cells. The 
hematopoietic cells comprise megakaryocytes and erythrocytic, myeloid, and lymphocytic cells. 
The bone marrow stroma consists of a heterogeneous cell population, which provides mechanical 
and physiological support to the hematopoietic cells (Summerfield et al., 2001). They include stem 
cell-like cells that under specific culture conditions can differentiate into osteocytes, chondrocytes 
and adipocytes. Mesenchymal stromal cells drive the differentiation of hematopoietic cells and are 
characterized by their ability to adhere to cell culture plates and their expression of specific surface 
markers such as CD44, CD55, CD73, CD29 and CD90 (Dominici et al., 2006; Wagner et al., 2007; 
Nesselmann et al., 2008). Leukocyte progenitor cells are used in the treatment of red bone marrow 
defects either inherited or caused by disease. Red bone marrow defects may also be caused by 
chemo- or radiotherapy and restored by transplanting auto- or allogenic cells (Zimmermann et al., 
2010). There are however limitations regarding the availability of red bone marrow hematopoietic 
cells for fundamental research. To date, human and mouse red bone marrow is widely used as a 
source of hematopoietic progenitor cells. However, in man only a little amount of bone marrow can 
be obtained by biopsy under strict ethical conditions, while in mice, red bone marrow is not always 
accessible in sufficient quantities, resulting in euthanasia of large numbers of mice (Ingesoll et al., 
2010). This is in conflict with the 3R principle of animal welfare. In contrast, pigs are ideal donors 
as large amounts of hematopoietic cells can be isolated from their bones upon euthanasia. It is 
therefore interesting to use the pig as a model for a better understanding of how the interactions 
between the different red bone marrow cell populations control their proliferation and differentiation 
after co-culture with mesenchymal cells. Some groups reported that cell culture medium 
supplemented with horse serum, pig serum, and cytokines such as interleukin (IL)-34, IL-4 and 
macrophage colony stimulating factor (M-CSF) (Chitu et al., 2006; Garceau et al., 2010) enhances 
the expansion and maturation of red bone marrow hematopoietic cells particularly in humans and 
mice (Zhang et al., 2008). Other authors reported that red bone marrow cell cultures supplemented 





hematopoietic cells (O’Neill et al., 2004). In the present work, we established a technology to 
generate viable and proliferative cells by co-culturing red bone marrow hematopoietic cells with 
immortalized mesenchymal stromal cells in a long-term, simple, affordable and effective cell culture 
system. 
 
3.3 Materials and Methods 
 
3.3.1 Donor animals and culture of red bone marrow mesenchymal stromal cells 
 
Tissues used for these experiments were taken from three 5 to 8-week-old conventional Belgian 
landrace pigs that were euthanized for other experiments. The euthanasia of the pigs was performed 
by jugular vein injection of 20% sodium pentobarbital (1 ml/1.5 kg; Kela laboratories, Hoogstraten 
Belgium). This is in agreement with the requirements of the Local Ethical and Animal Welfare 
Committee of the Faculty of Veterinary Medicine of Ghent University. Femur bones were 
aseptically removed and immediately placed in ice-cold transport medium containing phosphate 
buffered saline (PBS; Vel chemicals UBC, Brussels, Belgium), 0.1 mg/mL gentamicin (Invitrogen, 
Gent, Belgium), 0.1 mg/mL streptomycin (Certa, Eigenbrakel, Belgium), and 100 U/mL penicillin 
(Continental Pharma, Puurs, Belgium). Later, the bone was cut at both ends and the capita were 
removed using a sterilized saw. A twenty milliliter syringe with an eighteen-gauge needle was used 
to flush the red bone marrow with RPMI-1640 supplemented with 0.1 mg/mL gentamicin 
(Invitrogen), 0.1 mg/mL streptomycin (Certa), 100 U/mL penicillin (Continental Pharma). 
Aggregates were disintegrated by pipetting gently and the cell suspension was filtered through a 70 
μm cell strainer. The cell suspension was centrifuged at 430 x g at 4°C for 10 minutes and the cell 
pellet was resuspended in RBC lysis buffer (10 mM KHCO3, 150 mM NH4Cl, 0.1 mM EDTA (pH 
8)) and incubated on ice for 10 minutes. Later, the cells were washed two times in RPMI 








3.3.2 Establishment of primary mesenchymal cell stromal culture 
 
Immediately after isolation, as described above, red bone marrow cells were resuspended in 
Dulbecco’s Minimum Modified Eagle Medium (DMEM) supplemented with 10% FCS, 0.1 mg/mL 
gentamicin (Invitrogen), 0.1 mg/mL streptomycin (Certa), 100 U/mL penicillin (Continental 
Pharma) and seeded in 24 well plates, kept at 37°C 5% CO2. Three days post-seeding, half of the 
medium (500 µl) was replaced with fresh medium. This was repeated every 48 hours for 10 days. 
At 95% confluency, the fibroblast-like cells were split in 0.25% trypsin.  
 
3.3.3 Immortalization of primary mesenchymal stromal cells  
 
To obtain continuous cell cultures of mesenchymal stromal cells, the primary cells were 
immortalized with simian virus 40 (SV40) large T antigen. At 50% confluency, a recombinant 
lentivirus vector containing the sequence encoding SV40LT transforming protein (Applied 
biological materials Inc., Canada) (1:1) was added to the proliferating primary mesenchymal stromal 
cells in the presence of polybrene (8 µg/mL, Applied biological material Inc., Canada). Thirty 
minutes later, supernatant was diluted with complete medium to avoid toxicity and the cells were 
further incubated overnight. Subsequently, fresh medium was replaced. Seventy-two hours post-
transduction, cells were trypsinized with 0.25% trypsin (Sigma-Aldrich) and reseeded at a ratio of 
1:3. The cells were monitored every day for their expansion by light microscopy (Olympus).  
 
3.3.4 Immunofluorescence staining of immortalized mesenchymal stromal cells and analysis 
by confocal microscopy 
 
To confirm that primary mesenchymal stromal cells were successfully immortalized, transduced 
mesenchymal stromal cells were plated and allowed to attach to a glass cover slide overnight, 
washed two times with PBS, and fixed with 4% paraformaldehyde at room temperature for 10 
minutes. The cells were washed with PBS and permeabilized with Triton X-100 at room temperature 
for two minutes. Subsequently, the cells were incubated with polyclonal rabbit antibodies against 
SV40LT (Applied Biological material Inc.) antigen for 1 h at 37°C in the presence of 10% negative 





IgG-FITC for 1 h at 37°C. The cells were additionally washed two times with PBS. Later, the nuclei 
were counterstained with Hoechst 33342 for 10 minutes at 37°C.  The cells were washed and the 
cover slide was mounted with glycerin/PBS solution (0.9:0.1, v/v) with 2.5% 1,4-diazabicyclo 
[2.2.2] octane and analyzed by confocal microscopy (Leica Microsystem DMRBE, Wetzlar, 
Germany). To confirm the identity of the cells, a phenotypic characterization of the cells was also 
performed by immunofluorescence staining. Cells seeded on cover slides were washed two times 
with PBS and fixed with 4% paraformaldehyde at room temperature for 10 minutes. After two 
washes with PBS, the cells were permeabilized by incubation with Triton X-100 for two minutes at 
room temperature. The cells were rinsed with PBS and incubated with polyclonal rabbit antibodies 
against CD44 (ab157107, 1:200, Abcam) and CD55 (ab96680, 1:200, Abcam) containing 10% 
negative goat serum at 37°C for 1 h. Next, cells were incubated with FITC-conjugated goat anti-
rabbit IgG secondary antibodies for 1 h at 37°C. Subsequently, after two washes the nuclei were 
counterstained with Hoechst 33342 for 10 minutes at 37°C. Finally, the cells were washed two times 
in PBS and the slide was inverted on a small drop of glycerin/PBS solution (0.9:0.1, v/v) with 2.5% 
1,4-diazabicyclo [2.2.2] octane and analyzed by confocal microscopy (Leica Microsystem DMRBE, 
Wetzlar, Germany). 
 
3.3.5 Isolation of red bone marrow hematopoietic cells and co-culture 
 
Red bone marrow hematopoietic cells were isolated from three different piglets using the same 
methods described for isolating mesenchymal stromal cells. Immediately after the isolation, red 
bone marrow hematopoietic cells were resuspended in DMEM supplemented culture medium and 
seeded on top of the immortalized mesenchymal stromal cells monolayer at the concentration of 
2x105 cells/ml. Immortalized mesenchymal stromal cells were seeded at concentration of 1x106 24 
h prior to isolation of hematopoietic cells. The immortalized mesenchymal cells and hematopoietic 








3.3.6 Selection of culture medium for co-culturing red bone marrow hematopoietic cells with 
immortalized mesenchymal stromal cells 
 
To select the optimal culture conditions for the red bone marrow hematopoietic cell survival and 
proliferation in the presence of mesenchymal stromal cells, different culture media were tested. 
Immediately after isolation as described above, 1 x 106 cells/mL red bone marrow cells were 
resuspended in four different culture conditions: Dulbecco’s Modified Eagle Medium (DMEM), 
DMEM combined with Ham’s F-12 medium (DMEM/F-12) at a ratio of 1:1, Iscove’s modified 
Dulbecco eagle medium (IMDEM; serum-free medium) and RPMI-1640 combined with Minimum 
Essential Medium (RPMI/MEM) at a ratio 1:1. Each medium except IMDEM was supplemented 
with 10% FCS. Furthermore, all media were supplemented with 0.1 mg/mL gentamicin (Invitrogen), 
0.1 mg/mL streptomycin (Certa), 100 U/mL penicillin (Continental Pharma). Subsequently, the cells 
were seeded in 24-well plates containing a confluent monolayer of immortalized mesenchymal 
stromal cells cultured 24 hours prior to red bone marrow cell isolation. Every three days 500 µl of 
medium was replaced with fresh medium. Cells were collected from each culture condition every 
week at a concentration of 1 x105 cells/ml. After two washings, cells were resuspended in 400 µl 
PBS and incubated with propidium iodide (PI) on ice for 10 minutes and analyzed on a FACSCanto 
flow cytometer (BD bioscience). 
 
3.3.7 Follow-up of the co-culture of red bone marrow hematopoietic cells with immortalized 
mesenchymal stromal cells  
 
The co-culture was maintained in DMEM supplemented culture medium. Half of the medium (500 
µl) was gently replaced twice a week. To passage the co-culture, hematopoietic cells were gently 
collected in calcium containing phosphate buffered saline and transferred into a 50 ml Falcon tube. 
Later, the mesenchymal stromal cells were trypsinized with 0.25% trypsin (Sigma-Aldrich) and 
transferred to a new 50 ml falcon tube. Both cell types were washed in PBS and reseeded in new 








3.3.8 Red bone marrow hematopoietic cell morphology and proliferation analysis 
 
The morphology of the red bone marrow hematopoietic cells was examined on top of immortalized 
mesenchymal stromal cells by light microscopy and photographed during a period of 5 weeks. To 
examine the morphology of the red bone marrow hematopoietic cells, a Differential-Quick staining 
was performed. In the meantime, the proliferation of the red bone marrow hematopoietic stromal 
cells was assessed. Red bone marrow cells were seeded at a concentration of 1x105 cells/mL as 
described above on top of immortalized mesenchymal stromal cells in 24-well plate in a DMEM 
supplemented culture medium. One week post-seeding, red bone marrow hematopoietic cells from 
three randomly selected wells were gently collected in PBS supplemented with calcium. Red bone 
marrow hematopoietic cells were centrifuged at 270 x g for 10 minutes and resuspended in fresh 
culture medium. The cells were diluted 1/10 in PBS. This cell suspension (200 µl) was mixed with 
100 µl of 0.4% trypan blue and the cells were counted by light microscopy. The cell suspension was 
reseeded in 24-well culture plates and used for FACS analysis the following day. Counting was 
repeated every week for five consecutive weeks.  
 
3.3.9 Flow cytometric analysis  
 
A phenotypic analysis of the red bone marrow hematopoietic cells was performed. Every week, cells 
were gently collected from the co-culture in calcium containing PBS. Cells at a concentration of 1 
x 105/mL were washed in PBS containing 5% FCS and 1 mM EDTA, and incubated with one of the 
following primary antibodies: mouse anti-pig CD172a (DH59B, 1:100, IgG1, VMRD), mouse anti-
pig CD169 (41D3, 1:100, IgG1), mouse anti-pig CD163 (2A10/11, 1:100, IgG1, AbD Serotec, 
Dusseldorf, Germany), mouse anti-pig CD14 (Mil2, 1:100, IgG2b, Karen Haverson Laboratory), 
mouse anti-pig CD8 (76.2.11, 1:5, IgG2a) and mouse anti-pig CD4 (74.12.4, 1:5 IgG2b). After 
washing, the cells were incubated with 10% negative goat serum at 4°C for 10 minutes. 
Subsequently, the cells were incubated with a 1:200 dilution of FITC-labeled goat-anti-mouse IgG 
(Molecular Probes). Specificity of the staining for different cell markers was demonstrated using 
irrelevant, isotype-matched controls. Cells were washed twice and resuspended in 400 µl PBS. Prior 
to analysis on the FACSCanto cytometer (Becton Dickinson Immunocytometry systems) cells were 




for 30 minutes in the dark at 4°C. Collection and analysis of data were performed with FACS diva 
software (BD bioscience). 
 
3.4 Statistical analysis 
 
Statistical significance (P<0.05) was calculated using the Friedman test followed by Dunn’s 
multiple comparison test to determine the difference between the cell markers expressed and also 




3.5.1 Immortalization of mesenchymal stromal cell cultures and identification of the cells 
 
Porcine red bone marrow cells were isolated by flushing femur bones in RPMI-1640, yielding 
approximately 108 cells per femur. Two hours post-seeding, the majority of red bone marrow 
hematopoietic cells were found at the bottom of the flask. Three days after seeding, a large number 
of elongated fibroblast-like mesenchymal stromal cells adhered to the bottom of the culture plate 
and started to proliferate. Although mesenchymal stromal cells can stay in co-culture for more than 
one week without going into senescence, it was difficult to passage the cells more than two times. 
This adversely affected the survival of the hematopoietic cells. For this reason, the cells were 
immortalized by transduction with lentivirus vector SV40LT. Confirmation of successful 
immortalization of the mesenchymal stromal cells was performed by immunofluorescence staining. 
The mesenchymal stromal cells were found to be uniformly positive for SV40L nuclear antigen 
(Figure 1). Proliferation and viability of the cells decreased two to three weeks post-transduction 
after which the cells started to grow faster again. The morphology of the transduced cells was similar 
to that of primary cells. To confirm that the immortalized cells were mesenchymal stromal cells, 
immunofluorescence staining was performed to assess the expression of CD44 and CD55. The 







Fig 1. Immunodetection of SV40LT in immortalized mesenchymal stromal cells and characterization of the cells. 
Immunofluorescence staining was performed to confirm the successful immortalization of mesenchymal cells. The cells 
were uniformly positive for the large T virus antigen of SV40. Scale bar = 500 µm. Immunofluorescence staining of the 
immortalized mesenchymal cells was performed to demonstrate the expression of mesenchymal specific markers CD44 
and CD55 by these cells. Nuclei were counterstained with Hoechst. Scale bar = 10 µm. 
3.5.2 Selection of optimal medium to maintain co-cultures  
 
We next determined the optimal medium to maintain co-cultures of red bone marrow hematopoietic 
cells and immortalized mesenchymal stromal cells. Among the different culture media tested, 
DMEM + 10% FCS seemed most suited as the cells still had a viability of more than 90% during 5 
weeks of culture. The viability of cells cultured in RPMI-1640/MEM and F-12/DMEM was slightly 
lower than those in DMEM. Culture in IDMEM resulted in a viability drop of 50% after 3 weeks of 
culture and 90% after 5 weeks of culture (Fig 2).  
3.5.3 Proliferation analysis and identification of red bone marrow hematopoietic cells co-
cultured with immortalized mesenchymal stromal cells 
 
To further characterize the cells, both live and stained (Differential-Quick staining) fixed cells were 
analyzed weekly using light microscopy. The majority of freshly isolated red bone marrow 
hematopoietic cells were small in size, round with smooth borders and a dark nucleus (Fig 3; row 
1, week 0). From three days post seeding most of the red bone marrow hematopoietic cells increased 
in size, some became elongated, rough, and granular with tiny dendrites (Fig 3; row 1, week 2 and 
3). Four to five weeks of culture, the majority of red bone marrow hematopoietic cells clumped 
together, while some remained single large cells, elongated cells or round cells (Fig 3; row 1, week 
4 and 5). 
Analysis by a differential-quick staining indicated the presence of granulocytes (blue arrow; note 




lymphocytes (black arrow; note the round nucleus and scanty cytoplasm), and many other cell types 
in freshly isolated red bone marrow hematopoietic cells (Fig 3; row 2, week 0). The cell types 
observed during the subpassages for 1-5 weeks resembled monoblasts (red arrow; round to oval 
nucleus with broad rim of cytoplasm), monocytes (brown arrow; note the bean-shaped nucleus with 
small amount of cytoplasm), macrophages (green arrow; note the bean-shaped nucleus, the 
cytoplasm is coarsely granular with small vacuoles) and lymphocytes (black arrows; note the scanty 
cytoplasm). To check if the porcine red bone marrow hematopoietic cells cultured on top of 
immortalized mesenchymal stromal cell monolayers were proliferating, the cells were collected 


















Fig 2. Effect of culture medium on the viability of red bone marrow hematopoietic cells co-cultured with 
immortalized mesenchymal stromal cells. Red bone marrow hematopoietic cells were co-cultured in DMEM, RPMI, 
F-12+DMEM all supplemented with 10% FCS and IDMEM, serum free medium. DMEM supplemented with 10% FCS 
was the best culture condition producing almost 90% of viable cells five week post-seeding. The chart represents the 
mean and standard deviation of three independent experiments. 
 
After two hours the contaminating fibroblast-like mesenchymal stromal cells were attached to the 
bottom of the culture plates, while the hematopoietic cells remained in suspension. The non-attached 
cells were collected and counted by trypan blue exclusion test. The initial number of cells was 





bone marrow hematopoietic cell number increased to 7x105 /mL (see Fig 3; row 3). After six weeks 
of co-culture with immortalized mesenchymal stromal cells, the majority of hematopoietic cells 
differentiated, therefore their proliferation rate declined. Later on hematopoietic cells completely 
stopped proliferating. 
 
3.5.4 Phenotypical analysis of differentiating hematopoietic cells 
 
The main populations of red bone marrow hematopoietic cells were categorized based on their light 
scatter properties and by comparing them with peripheral mononuclear cells (PBMC).  
 
 
Fig 3. Analysis of the morphology and proliferation of red bone marrow hematopoietic cells co-cultured with 
immortalized mesenchymal stromal cells. The cell morphology was examined by phase contrast microscopy every 
week for 5 weeks. At week 0, differential-quick staining of the cells revealed cells with a segmented nucleus (myeloid 
cells; blue arrow) and cells with a slightly indented nucleus (monocytic cells; yellow arrow). A large number of blast 
cells (red arrow) and few monocytes (brown arrow), macrophage (green arrow) and lymphocytes (black arrow) were 
also observed during 1-5 weeks of co-culture (row 2). Proliferation capacity of the bone marrow hematopoietic 
progenitor cells was assessed. Cells were collected from the cultures, washed and counted every week for five weeks. 







To investigate the phenotype of the red bone marrow hematopoietic cells co-cultured with 
immortalized mesenchymal stromal cells, the expression of the surface markers CD172a, CD14, 
CD163, CD169, CD4 and CD8 was analyzed, after dead cells, cell debris and doublet cells were 
excluded. During the measurement, all parameters were kept constant. Generally, the size and 
granularity of the cells increased from 0 to 5 weeks (results not shown). The percentage of CD172a, 
CD14, CD163, CD169 CD4 and CD8 positive red bone marrow hematopoietic cells was determined 
on a fluorescence versus forward scatter dot plot (Figure 4a and 4b). Analysis of flow cytometry 
data showed that 2.0±3% of freshly isolated red bone marrow hematopoietic cells were positive for 
CD172a. At week 1, 2, 3, 4 and 5, 5±7%, 22±10%, 37±0.8%, 22±7% and 18±2% of the red bone 
marrow hematopoietic cells were CD172a+, respectively. CD14 was expressed on 5±3% of freshly 
isolated red bone marrow hematopoietic cells and on 32.0±4%, 34.0±6%, 40.0±8%, 27.0±1% and 
39.0±7% of red bone marrow hematopoietic cells co-cultured with mesenchymal stromal cells at 1, 
2, 3, 4, and 5 weeks of co-culture, respectively. The percentage of CD163+ cells in freshly isolated 
red bone hematopoietic cells was 1.5±11%, and 7.0±10%, 18.0±2%, 41.0±4%, 12.0±6% and 
22.0±9% in red bone marrow hematopoietic cells co-cultured with mesenchymal stromal cells for 
1, 2, 3, 4, and 5 weeks, respectively. Two CD163+ cell populations were found when red bone 
marrow hematopoietic cells were co-cultured with mesenchymal stromal cells for two weeks 
(CD163low and CD163high). CD169 was not present on freshly isolated red bone marrow 
hematopoietic cells and red bone marrow hematopoietic cells co-cultured with mesenchymal 
stromal cells for one week. However, at 2, 3, 4 and 5 weeks of co-culture 7.0±2%, 24.0±2%, 
7.0±4%, and 7.0±0.5% of the red bone marrow hematopoietic cells were CD169 positive. CD4 was 
also not present on freshly isolated red bone marrow hematopoietic cells while 1.0±14%, 6.0±3%, 
23.0±3%, 5.8±1% and 11.0±4% of the red bone marrow hematopoietic cells were positive for CD4 
at week 1, 2, 3, 4, and 5, respectively. Among the freshly isolated red bone marrow hematopoietic 
cells 4.1±4% of the cells expressed CD8. At 1, 2, 3, 4 and 5 weeks of co-culture, 1.8±4%, 4.3±6%, 
19.0±5%, 1.5±6% of the red bone marrow hematopoietic cells were positive for CD8 respectively. 
Three weeks post-seeding in the presence of mesenchymal stromal cells, a significant increase 
(p<0.05) in the percentage of CD163, CD169 and CD8 positive red bone marrow hematopoietic 
cells was observed when compared to freshly isolated cells and red bone marrow hematopoietic 





CD14, and CD4 a trend in increased expression of these markers was also observed when freshly 
isolated red bone marrow hematopoietic cells were compared with red bone marrow hematopoietic  
cells co-cultured with mesenchymal stromal cells for 1, 2 and 3 weeks (Fig 4a and 4b).  
 
 
Fig 4. Phenotypical analysis of red bone marrow hematopoietic cells. Cells at concentrations of 1 x 105/mL were 
washed in PBS containing 5% FCS and 1 mM EDTA, and incubated with mouse monoclonal antibodies against porcine 
CD172a CD14, CD163, CD169, CD4 and CD8. The results of the flow cytometry analysis are shown as fluorescence 
(y-axis) versus forward scatter (x-axis) dot plot. Chart data from three independent experiments were presented as 








In this study, porcine red bone marrow hematopoietic cells were co-cultured with immortalized 
mesenchymal stromal cells for five weeks. This co-culture led to a 3-fold proliferation and 90±3.2% 
viable hematopoietic cells. These results are in line with previous findings that human bone marrow 
derived-mesenchymal stromal cells support the maintenance and proliferation of bone marrow 
hematopoietic cells in in vitro cultures (de Lima et al., 2012; Walenda et al., 2010). That success 
was attributed to the secretion of some soluble factors and cell-to-cell contacts (Wagner et al., 2007). 
During the co-culture of red bone marrow hematopoietic cells with immortalized mesenchymal 
stromal cells, a differentiation of the hematopoietic cells toward monocytes/macrophages (40%) and 
CD4 and CD8 cells (20-25%) was demonstrated by the use of myelomonocytic and lymphocytic 
markers (Hsu et al., 2007). Although many groups used a medium supplemented with different 
cytokines and growth factors to maintain red bone hematopoietic cells in culture, we were able to 
keep the cells for five weeks in a simple cell culture condition containing DMEM supplemented 
with 10% fetal calf serum on top of a monolayer of immortalized CD44+CD55+ mesenchymal 
stromal cells. However, six weeks post-seeding hematopoietic cells with immortalized 
mesenchymal stromal cells, the proliferation rate gradually decreased as more cells differentiated 
and finally stopped. 
CD172a is a pan-myeloid marker and was the first to be detected in porcine myelomonocytic cells.  
It was the first molecule that was expressed on myeloid cells, and continued to be expressed by these 
cells as they differentiated into more mature cells (Summerfield et al., 2001). CD172a plays an 
important role in the control of proliferation, differentiation and activation of myeloid cells 
(Ezquerra et al., 2008). This marker is detected at high levels on granulocytes, monocytes, 
macrophages and dendritic cells (van Beek et al., 2005), but compared to monocytes, the levels on 
DCs and macrophages are low. FACS data from this study indicated an increased expression of 
CD172a on red bone marrow hematopoietic cells co-cultured with mesenchymal stromal cells for 
three weeks when compared with freshly isolated red bone marrow hematopoietic cells. The 
CD172a+ cells had a high forward scatter and side scatter (Ezquerra et al., 2008). This is in 
agreement with the findings that bone marrow cells cultured in the presence of colony stimulating 





side scatter properties with time (maximum of 7 days) (Fairbairn et al., 2011; Kapetanovic et al., 
2012). The majority of these CD172a+ cells were observed to be blast cells, monocyte-like 
macrophages, and vacuolated macrophages (Sladek et al., 2014).  
CD14, the co-receptor for Gram-negative lipopolysaccharides (LPS), Gram-positive bacteria 
peptidoglycans and lipoteichoic acid is expressed at a high level by monocytes and tissue 
macrophages, but at lower levels by granulocytes. It is used in humans as a marker of monocytes 
and macrophages (Summerfield et al., 2001; Ezquerra et al., 2008). In humans, CD14 together with 
CD16 are mostly used as a marker to classify monocytes into different subsets. Mil2 is a pig CD14-
specific monoclonal antibody (Thacker et al., 2001) characterized by Haverson et al. (1994), while 
MY-4 is a multispecies reactive monoclonal antibody. Carrasco et al. 2001 and Thacker et al., 2001 
assessed and found no difference between MIL2 and MY-4 monoclonal antibodies in terms of 
detecting the CD14 expression on pig cells. The most unexpected finding of this study was that the 
percentage of CD14+ red bone marrow hematopoietic cells was higher compared to that of CD172a+ 
hematopoietic cells throughout the period of the experiment (five weeks), despite the latter being 
the pan-myeloid marker expressed by every myeloid cell from precursor to matured cells. In 
addition, CD14 was described as a monocyte marker expressed at a low level during maturation 
(Steinbach F et al., 1994).  
CD163, also called scavenger receptor cysteine-rich type 1 protein, is expressed only by monocytes 
(subset of monocytes) and macrophages and it is used as a maturation marker for monocytes. It 
plays a very important role in the infection of macrophages by African swine fever virus and porcine 
reproductive and respiratory syndrome virus. In this study, CD163+ cells were almost undetectable 
on freshly isolated red bone marrow hematopoietic cells, which is in agreement with a report from 
Sanchez et al. (1999). Furthermore, statistical analysis showed a significant increase in the 
expression of CD163 on red bone marrow hematopoietic cells co-cultured with immortalized 
mesenchymal stromal cells for three weeks when compared with freshly isolated red bone marrow 
hematopoietic cells. This is in line with the hypothesis that the expression level of CD163 in blood-
derived monocytes increases as the cell matures (Fairbairn et al., 2011; Kapetanovic et al., 2012). It 
has also been reported by the same authors that culturing porcine bone marrow hematopoietic cells 
in the presence of rhCSF-1 did not cause increased expression levels of CD163.  
Porcine sialoadhesin (CD169; siglec-1) has been identified as a sialic acid-dependent sheep 




binding immunoglobulin-like lectin family and is involved in the binding and internalization of 
porcine reproductive and respiratory syndrome virus (Vanderheijden et al., 2003; Crocker et al., 
1989; Hartnell et al., 2001). CD169 expression is restricted to specific macrophages residing in 
lungs, lymphoid tissues, liver and colon (Ezquerra et al., 2008). In the latter study, CD169 was not 
detected on freshly isolated and one week old porcine red bone marrow hematopoietic cells, which 
is in agreement with other studies in humans and mice (Duan et al., 1997). It was also reported that 
culturing freshly isolated porcine monocytes in medium supplemented with FBS or porcine serum 
causes a very low expression level of CD169 (Crocker et al 1988). We observed a high percentage 
of CD169+ cells (24±5%; p<0.05) in porcine red bone marrow hematopoietic cells, co-cultured with 
mesenchymal stromal cells for three weeks compared to freshly isolated red bone marrow 
hematopoietic cells. There were no CD4+ cells detected in freshly isolated and one week old porcine 
red bone marrow hematopoietic cells. Unlike CD4, CD8+ cells were detected in freshly isolated and 
one week old porcine red bone marrow hematopoietic cells. These CD8+ red bone marrow 
hematopoietic cells had a low forward scatter. From two weeks post seeding in the presence of 
mesenchymal stromal cells, these small CD4+ and CD8+ red bone marrow hematopoietic cells 
completely disappeared. Most likely these particular cells died out. This is in agreement with a 
report demonstrating an inhibition of CD8+ and CD4+ T cell proliferation by human bone marrow 
stromal cells (Vremee et al., 2000).  
In conclusion, in this work we successfully established a co-culture model for differentiating porcine 
red bone marrow hematopoietic cells on top of SV40LT immortalized mesenchymal stromal cells 
into cells of the monocyte/macrophage lineage and CD4 and CD8 cells. This co-culture model may 
be used to investigate the mechanism by which mesenchymal stromal cells trigger red bone marrow 
hematopoietic cell differentiation into cells of the monocyte/macrophage lineage in in vitro cultures. 
Although many research groups studied adhesion molecules in human mesenchymal stromal cells 
there is little understanding on how porcine mesenchymal stromal cells and red bone hematopoietic 
cells interact with each other by means of adhesion molecules such as CD44. As the pig is a good 
model for humans, this co-culture model may be an interesting tool to explore. This will allow the 
further development of the therapeutic potential of mesenchymal stromal cells in the near future. In 
addition, the monocytes/macrophages generated by this co-culture will be used to study the 
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Chapter 4 
               Immortalized porcine mesenchymal stromal cells         
               derived from nasal mucosa, lungs, lymph nodes,  
               spleen and bone marrow retain their stemness  
               properties and trigger the expression of siglec-1                  
in co-cultured blood monocytic cells 
 























Mesenchymal stromal cells have been isolated from different sources. They are multipotent cells 
capable of differentiating into many different cell types, including osteocytes, chondrocytes and 
adipocytes. They possess a therapeutic potential in the management of immune disorders and the 
repair of damaged tissues. In the previous chapter, we showed that the percentage of CD172a+, 
CD14+, CD163+, Siglec-1+, CD4+ and CD8+ hematopoietic cells increased when co-cultured with 
immortalized mesenchymal cells derived from bone marrow. The present work aimed to 
demonstrate the stemness properties of SV40-immortalized mesenchymal stromal cells derived 
from nasal mucosa, lungs, spleen, lymph nodes and red bone marrow and their immunomodulatory 
effect on blood monocytes. Mesenchymal stromal cells from nasal mucosa, lungs, spleen, lymph 
nodes and red bone marrow were isolated and successfully immortalized using simian virus 40 large 
T antigen (SV40LT) and later, co-cultured with blood monocytes, in order to examine their 
differentiation stage (expression of Siglec-1). Flow cytometric analysis revealed that the five 
mesenchymal cell lines were positive for mesenchymal stromal cell markers CD105, CD44, CD90 
and CD29, but lacked the expression of myeloid cell markers CD16 and CD11b. Growth analysis 
of the cells demonstrated that bone marrow derived-mesenchymal stromal cells proliferated faster 
compared with those derived from the other tissues. All five mesenchymal cell lines co-cultured 
with blood monocytes for 1, 2 and 7 days triggered the expression of siglec-1 in the monocytes. In 
contrast, no siglec-1+ cells were observed in monocyte cultures without mesenchymal stromal cell 
lines. Mesenchymal stromal cells isolated from nasal mucosa, lungs, spleen, lymph nodes and bone 
marrow were successfully immortalized and these cell lines retained their stemness properties and 










Mesenchymal stromal cells, also known as mesenchymal stem cells, are multipotent cells derived 
from the mesoderm during embryonic development (Pittenger et al., 1999; Gerson et al., 1999). 
They have been demonstrated by many research groups to be a potential tool in treating cardio-
vascular diseases, diabetes and autoimmune diseases, like rheumatoid arthritis as well as in 
regenerative medicine (Singla et al., 2010, Ling et al., 2009, Gonzalez-Rey et al., 2010). They have 
immunomodulatory properties, which they effect through many ways, one of which is the secretion 
of anti-inflammatory factors such as TGF-β (Di Nicola et al., 2002). They may inhibit the 
proliferation of lymphocytes and regulate the differentiation and function of dendritic cells (Nauta 
et al., 2006). Mesenchymal stromal cell co-cultures with macrophages trigger an increase in the 
expression of IL-10 and decrease the expression of TNF-α and IL-12 (Kim et al., 2009). In vivo 
experiments showed the accumulation of macrophages with a regulatory phenotype in inflamed 
areas upon local infusion of mesenchymal stromal cells. The short life span of primary mesenchymal 
stromal cells during in vitro cultivation prevents their use in long-term experiments (Wagner et al., 
2008; Bork et al., 2010; Stewart et al., 2002). Primary mesenchymal stromal cells have a limited 
number of cellular divisions in cell culture after which they undergo senescence and finally die 
(Stewart et al., 2002; Stewart et al., 2006). Because of these limitations, there is an urgent need to 
establish continuous cell cultures of well-characterized mesenchymal stromal cells for long-term 
studies. Presently, the most widely used method to immortalize primary cells is by introducing viral 
genes, such as the gene encoding simian virus 40 large T antigen (Jha et al., 1999, Kirchoff et al., 
2004).  
The ability to keep large quantities of mice for repetitive experiments makes it the most widely used 
animal for studying many human diseases and abnormalities. Many groups conducted research on 
the potential therapeutic application of mesenchymal stem cells in humans using mice models with 
successful outcome. However, its small size makes it impossible to collect large amounts of tissues 
for an experiment. Moreover, results obtained from experiments performed on mice may be difficult 
to successfully translate to human medicine (Orlie et al., 2001).  
Alternative large animal models may be developed with pigs, which are more closely related to 





of tissues can be obtained from pigs to conduct several experiments. Siglec-1, a protein expressed 
only on macrophages, plays a crucial role in host-pathogen interactions and immune regulation. 
Pathogens carrying sialic acids can be internalized by siglec-1+ macrophages (Delputte et al., 2011). 
It mediates the receptor-dependent internalization of PRRSV (Vanderheijden et al., 2003). In the 
present study, continuous cultures of mesenchymal cells from porcine nasal mucosa, lungs, spleen, 
lymph nodes and bone marrow were established and used to generate siglec-1+ macrophages. 
 
4.3 Materials and methods 
 
4.3.1 Cell isolation and cultures 
 
Three pigs were euthanized by injecting sodium pentobarbital (20%, 1ml/1.5 kg; Kela Laboratories, 
Hoogstraten Belgium) into the jugular vein. The pigs were euthanized for the purpose of other 
experiments with the approval of Local Ethical and Animal Welfare Committee of the Faculty of 
Veterinary Medicine of Ghent University (Application EC2015∕04). Nasal mucosa, lungs, spleen 
and lymph nodes were removed in a sterile way and transferred immediately to a biosafety cabinet. 
Tissues from these organs were cut into small pieces, transferred into sterile 100 ml bottles 
containing Dulbecco’s Modified Eagle’s Medium (DMEM) and incubated at 37°C for 1 h in the 
presence of 0.5 mg/ml collagenase type IV (Gibco). Next, the cell suspension was filtered using a 
70 μm cell strainer and washed two times with PBS. The cells were resuspended in DMEM 
supplemented with 10% fetal calf serum (FCS; Gibco), 1 mM sodium pyruvate, 1% non-essential 
amino acid, 0.1 mg/mL gentamicin (Invitrogen), 0.1 mg/mL streptomycin (Certa), and 100 U/mL 
penicillin (Continental Pharma). Cells were seeded in 24-well plates at a concentration of 1 x 106 
/ml. To deplete the cell cultures of mononuclear leukocytes, half of the medium was replaced every 
48 hrs for 1 week. At 80% confluency, spindle and elongated-shaped cells were trypsinized in 
0.125% trypsin solution (Sigma-Aldrich) and passaged. Isolation, cultivation, immortalization and 
characterization of red bone marrow mesenchymal stromal cells were described before (see Chapter 
3). To check the epithelial cell contamination in the immortalized mesenchymal cell cultures, at 
passage 11 the five immortalized mesenchymal stromal cell types were seeded in 24-well plate and 




paraformaldehyde at room temperature for 10 minutes. The cells were washed with PBS and 
permeabilized with Triton-X 100 at room temperature for two minutes. Next, the cells were 
incubated with monoclonal mouse anti-human cytokeratin (AE1/AE3, 1:200, IgG1, Dako Denmark 
A∕S) for 1 h at 37°C in the presence of 10% normal goat serum. The cells were washed two times 
with PBS and later incubated with secondary antibodies goat anti-mouse IgG1-FITC for 1 h at 37°C. 
The cells were additionally washed two times with PBS and the cover slide was mounted with 
glycerin/PBS solution (0.9:0.1, v/v) and analyzed by confocal microscopy (Leica Microsystem 
DMRBE, Wetzlar, Germany). Also to detect the presence of mononuclear cells in the immortalized 
mesenchymal stromal cell cultures. Cells were fixed with 4% paraformaldehyde for 10 min. at room 
temperature followed by permeabilization with Triton-X 100 for 2 min. at room temperature. The 
cells were washed two times with PBS and incubated with rabbit polyclonal antibodies to CD45 
(ab10558, 1:100, IgG, abcam) for 1 h at 37°C in the presence of 10% normal goat serum. The cells 
were washed two times with PBS and further incubated with secondary antibodies goat anti-rabbit 
IgG-FITC for 1 h at 37°C. After two times washing with PBS, the cover slide was mounted with 
glycerin/PBS solution (0.9:0.1, v/v) and analyzed by confocal microscopy (Leica Microsystem 
DMRBE, Wetzlar, Germany). Mesenchymal stromal cells derived from nasal mucosa, lungs, spleen 
and lymph nodes were monitored by light microscopy to examine their morphology.  
 
4.3.2 Immortalization of primary mesenchymal stromal cells 
 
To establish continuous cultures of mesenchymal stromal cells for long-term studies, cells were 
immortalized using recombinant lentivirus containing the sequence encoding the simian virus 40 
large T antigen (SV40LT) (Applied biological materials Inc., Richmond, BC, Canada). At 50% 
confluency, cells isolated from nasal mucosa, lungs, spleen and lymph nodes were incubated with 
an SV40LT gene carrying lentivirus suspension containing polybrene (8 μg/mL, applied biological 
material Inc., Richmond, BC, Canada). After 30 minutes, the virus was diluted with complete 
medium to prevent toxicity. Next, the cells were further incubated overnight. After 18 h incubation, 
the virus suspension was replaced with complete medium, after two times washing. The cells were 
allowed to proliferate for 2-3 days to 90-100% confluency. Three days post-transduction, cells were 
trypsinized with 0.125% trypsin (Sigma- Aldrich) and reseeded. The cells were examined every day 





mesenchymal stromal cells, transduced cells were seeded in 24-well plates on glass cover slips and 
incubated at 37°C, 5% CO2 for 24-48 h. Cells were washed two times with PBS and fixed with 4% 
paraformaldehyde for 10 min. at room temperature. Next, cells were additionally washed two times 
and permeabilized with Triton-X 100 at room temperature for two minutes. Subsequently, the cells 
were incubated with polyclonal rabbit antibodies against SV40LT (Applied Biological material Inc.) 
antigen for 1 h at 37°C in the presence of 10% normal goat serum. After two washes with PBS the 
cells were further incubated with goat anti-rabbit IgG-FITC for 1 h at 37°C. The cells were 
additionally washed two times with PBS and the cover slide was mounted with glycerin/PBS 
solution (0.9:0.1, v/v) with 2.5% 1,4-diazabicyclo [2.2.2] octane and analyzed by confocal 
microscopy (Leica Microsystem DMRBE, Wetzlar, Germany). 
 
4.3.3 Flow cytometry 
 
Immortalized mesenchymal stromal cells were analyzed for the expression of the mesenchymal 
stromal cell markers CD44, CD29, CD105 and CD90. As a negative control, the expression of the 
myeloid cell markers CD16 and CD11b were also examined. Immortalized mesenchymal stromal 
cells from nasal mucosa, lungs, spleen, lymph node and bone marrow cells were trypsinized with 
0.125% trypsin (Sigma-Aldrich) and washed two times in PBS containing 1 mM EDTA-5% FCS. 
The cells were incubated with the following primary mouse monoclonal antibodies: anti-CD44 
(F10-44-2, IgG2a, 1:200, abcam), anti-CD29 (7F10, IgG1, 1:200, THERMO Fischer Scientific Inc), 
anti-CD105 (MEM-229, IgG2a, 1:200, THERMO Fischer Scientific Inc.), anti-CD90 (3F9, IgG2a, 
1:200, Norvus Biological), anti-CD16 (G-7, IgG1, I:100, Antigenix America Inc.) and anti-CD11b 
(ab8879, IgG1, 1:400, abcam). To demonstrate the specificity of the primary antibodies, 13D12 
against gD of PrV (IgG1) and 1C11 against gB of PrV (IgG2a) were used as isotype controls 
(Nauwynck et al., 1995). The incubation was performed in the presence of normal goat serum for 
30 minutes on ice. After two washes, the cells were incubated with appropriate secondary 
antibodies: Alexa Fluor 647-conjugated goat anti-mouse IgG2a and Alexa Fluor 488-conjugated 
goat anti-mouse IgG1 for 30 minutes on ice in the dark. Next, the cells were washed two times, 
resuspended in 100 μl PBS and transferred to 96 well-plates. The measurement of cells and analysis 
of the results were performed with a cytoFLEX flow cytometer and cytoFlex software respectively 




4.3.4 Growth analysis of immortalized mesenchymal stromal cells 
 
To determine the proliferation rate of the immortalized mesenchymal stromal cells, the cells were 
seeded in six-well plates at 2 x 105/ml. Every 24 h, cells were trypisinized and counted during 5 
days at 24, 48, 72, 96 and 120 h. The growth analyses were performed in triplicate at each time 
point. 
 
4.3.5 Cell cycle analysis of immortalized mesenchymal stromal cells 
 
Immortalized mesenchymal stromal cells were trypsinized with 0.125% trypsin solution and washed 
two times in PBS. The cells were resuspended in ice-cold PBS and their concentrations adjusted to 
106 cells/ml. One ml of the cell suspension was gently vortexed and added dropwise to 9 ml of 70% 
ethanol in 15 ml centrifugation tubes. The cells were incubated at 4°C for 2 hours and then 
centrifuged at 450 x g at 4°C for 10 min. Subsequently, the cells were resuspended in 300 μl 
propidium iodide (1 mg/ml)/Triton X-100 (0.1%) solution containing 2 mg DNase-free RNase A 
(Sigma-Aldrich). Later, the cells were incubated at 37°C for 15 minutes in the dark. Next, the cells 
were transferred to 4°C until measurement. A CytoFLEX flow cytometer (Beckman Coulter, Inc.) 
was used to acquire and analyze the data. 
 
4.3.6 Osteogenic, chondrogenic and adipogenic differentiation of immortalized mesenchymal 
stromal cells 
 
Immortalized mesenchymal stromal cells derived from nasal mucosa, lungs, spleen, lymph nodes 
and red bone marrow were resuspended in complete medium and seeded in 24-well plates at a 
concentration of 1 x 105 cells/ml. The cells were incubated at 37°C in a humidified atmosphere of 
5% CO2. At 60% confluency, medium was replaced with complete osteogenic differentiation 
medium (StemPRO® osteogenesis Differentiation Kit; Gibco) and the cells were further incubated. 
The cell cultures were refed every 3 days. After 5 days of culturing, osteogenic differentiation 
medium was gently removed and mesenchymal stromal cells were washed two times with PBS. The 
cells were fixed with 4% parafomaldehyde for 30 minutes at room temperature (RT). The cells were 





minutes. After removal of the staining solution, cells were washed two times with PBS and analyzed 
by light microscopy. Adipogenic differentiation of the mesenchymal cells was performed by 
culturing mesenchymal stromal cells in adipogenic differentiation medium (StemPRO® 
Adipogenesis Differentiation Kit; Gibco) for 5 days. To demonstrate the presence of lipid droplets 
in differentiated mesenchymal stromal cells, adipogenic differentiation medium was removed. Next, 
the cells were washed two times with PBS and incubated with 4% paraformaldehyde for 30 minutes 
at room temperature. Later, 200 μl oil red O was added to the cells and incubated for 1 h at room 
temperature. The cells were washed two times with PBS and analyzed using light microscopy. For 
chondrogenesis, mesenchymal cells were cultured in chondrogenic differentiation medium 
(StemPRO® Chondrogenesis Differentiation Kit; Gibco) for 7 days. The cell cultures were refed 
every 3 days. To confirm the differentiation of mesenchymal stromal cells to chondrocytes, cells 
were incubated with alcian blue staining solution for 30 minutes at RT. The cells were then washed 
two times with PBS and analyzed by light microscopy.  
 
4.3.7 Culturing immortalized mesenchymal stromal cells in media supplemented with 
cytokine-free serum 
 
After detachment, immortalized mesenchymal stromal cells derived from nasal mucosa, lungs, 
spleen, lymph nodes and red bone marrow were suspended in DMEM supplemented with 10% 
cytokine-free serum, 0.1 mg/mL gentamicin (Invitrogen), 0.1 mg/mL streptomycin (Certa), and100 
U/mL penicillin (Continental Pharma). The cells were seeded at 2 x 105 cells/ml in 24-well plates 
and incubated in a humidified environment of 5% CO2 at 37°C. After 3 days of culture the cells 
were trypsinized using 0.125% trypsin and washed two times. Next, the cells were resuspended in 
100 μl PBS in 96-well plates and incubated with 1 mg/ml propidium iodide (PI; Sigma-Aldrich) for 










4.3.8 Co-culturing of immortalized mesenchymal stromal cells and blood monocytes 
 
4.3.8.1 Isolation of blood mononuclear cells 
 
Blood was taken from three pigs, using 20 ml syringes with 18-gauge needles. The blood was 
transferred into a sterile 50 ml Falcon tube and diluted 1:1 with ice-cold PBS. Twenty milliliter of 
diluted blood was gently layered on top of 15 ml Ficoll-paque in a 50 ml tube and centrifuged at 
450 x g for 45 min. at RT. The interphase band containing mononuclear cells was gently removed 
and transferred into a new Falcon tube. After centrifugation, the cells were suspended in lysis buffer 
and incubated on ice for ten minutes. The cells were washed two times with PBS and resuspended 
in RPMI/MEM (1:1) supplemented with 10% fetal calf serum (FCS), 1 mM sodium pyruvate, 1% 
non-essential amino acid, 0.1 mg/mL gentamicin (Invitrogen), 0.1 mg/mL streptomycin (Certa), and 
100 U/mL penicillin (Continental Pharma). Next, the cells were seeded in 24-well plates on inserts 
at a concentration of 106 cells/ml. The cells were incubated at 37°C, 5% CO2. 
 
4.3.8.2 Co-culture of peripheral blood monocytes and immortalized mesenchymal stromal cells 
 
Eighteen hours post-seeding, non-adherent cells were gently removed by washing. Next, 3 x104/ ml 
immortalized mesenchymal stromal cells from nasal mucosa, lungs, spleen, lymph nodes and red 
bone marrow were added to the monocytic cell cultures in DMEM supplemented with 10% fetal 
calf serum (FCS), 1 mM sodium pyruvate, 1% non-essential amino acid, 0.1 mg/mLgentamicin 
(Invitrogen), 0.1 mg/mL streptomycin (Certa), and 100 U/mL penicillin (Continental Pharma). 
Wells with only monocytic cells were used as controls. The immortalized mesenchymal stromal 
cell-monocytic cell co-cultures were incubated at 37°C, 5% CO2. The co-cultures were fixed with 
4% paraformaldehyde for 10 minutes at RT at 24 h, 48 h and 1week post-seeding. After 
permeabilization with 0.1% Triton X-100 at RT for 2 minutes, the cells were incubated with porcine 
anti-siglec-1 (41D3, IgG1, 1:5) or porcine anti-CD163 (2A10/11, IgG1, 1:200, AbD Serotec, 
Dusseldorf, Germany) primary antibodies containing normal goat serum for 1 h at 37°C. After two 
washes, the cells were incubated with goat anti-mouse IgG Alexa-Fluor 594 (A-21125, 1:400, 
invitrogen) secondary antibodies for 1 h at 37°C. Hoechst 33342 was used to stain the nuclei of the 





the primary antibodies used, isotype-matched control monoclonal antibodies against gD of PRV 
(IgG1, 13D12) were used (Nauwynck et al., 1995). The cells were rinsed with PBS and mounted 
with glycerin/PBS solution (0.9:0.1, v/v) with 2.5% 1,4-diazabicyclo [2.2.2] octane. Next, the 
siglec-1 and CD163 positive cells were determined by counting a total of 500 cells per slide using 
fluorescence microscopy and photographed by confocal microscopy (Leica Microsystem DMRBE, 
Wetzlar, Germany). Subsequently, ImageJ software (U.S. National Institutes of Health, Bethesda, 
Maryland, USA) was used to calculate the fluorescence intensity of the siglec-1+ and CD163+ cells. 
 
4.4 Statistical analysis 
 
Descriptive statistics was used to determine the difference in the percentage and expression of 
siglec-1 and CD163 by monocytic cells co-cultured with mesenchymal stromal cells derived from 




4.5.1 Immortalizing mesenchymal stromal cells from different tissues does not affect their 
morphology 
 
Seventy-two hours after seeding, a variety of cells attached to the culture plates. The cells included 
mononuclear cells, epithelial-like cells and elongated fibroblast-like cells. Passaging the cells 
depleted the epithelial-like cells and mononuclear cells, leaving fibroblast-like cells in culture which 
continued to proliferate. This was confirmed by staining the five immortalized mesenchymal 
stromal cell types with antibodies against the epithelial cell marker cytokeratin and leukocyte marker 
CD45. No cytokeratin positive cells were found and no CD45 positive cells were observed in all the 
five immortalized mesenchymal stromal cell cultures. The mesenchymal stromal cells from nasal 
mucosa, lungs, spleen and lymph nodes were confirmed to be successfully immortalized by the 
expression of SV40LT antigens (Fig 1). The morphology of the immortalized stromal cells was 




morphology (Fig 1). The mesenchymal stromal cells from nasal mucosa, lungs, spleen, lymph node 
and red bone marrow have been passaged 32 times without any problem regarding their morphology 
and growth characteristics. 
 
 
Fig 1. Morphological analysis of the immortalized mesenchymal stromal cells. Top row: the morphology of the 
immortalized mesenchymal stromal cells. Scale bar ꞊꞊ 10 μm. Bottom row: mesenchymal cells expressed nuclear 
localized SV40TL antigen. Scale bar ꞊꞊ 50 μm.  
4.5.2 The mesenchymal stromal cell specific marker profile is not affected by immortalization 
 
Immortalized mesenchymal stromal cells derived from nasal mucosa, lungs, lymph nodes, spleen 
and bone marrow were analyzed for the expression of mesenchymal stromal cell specific markers 
by flow cytometry. The five mesenchymal stromal cell lines expressed CD105, CD90, CD44 and 
CD29, but were negative for CD16 and CD11b (Fig 2A, B). The percentages of CD105+, CD90+, 
CD44+ and CD29+ immortalized mesenchymal stromal cells were 97±3%, 94±4%, 96±3% and 
42±9%, respectively, in cells from nasal mucosa; 84±11%, 96±3%, 260 93.8±% and 29±3%, 
respectively, in cells from lungs; 86±6%, 85±3%, 81±1% and 41±2%, respectively, in cells from 
spleen; 92±0.5%, 95±0.6%, 91±2% and 34±2%, respectively, in cells from lymph nodes; 70±11%, 
82±5%, 70±4% and 34±2%, respectively, in cells from red bone marrow. 
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Fig 2. Characterization of immortalized mesenchymal stromal cells by flow cytometry. Immunophenotyping was 
performed for detection of specific cell markers known to be expressed by mesenchymal stromal cells (CD44, CD105, 






4.5.3 Immortalized mesenchymal stromal cells from different tissues display equal growth 
curves 
The five immortalized mesenchymal stromal cell types showed a similar growth pattern especially 









Fig 3. Proliferation analysis of the immortalized mesenchymal stromal cells. Growth pattern of the five 
immortalized mesenchymal stromal cells. The data are represented as mean +/- SD of three independent experiments. 
Five hours after seeding, 90% of the immortalized mesenchymal stromal cells derived from lungs, 
spleen and lymph nodes attached to the bottom of the culture plates and started to spread. Only 50% 
of the nasal mucosa mesenchymal stromal cells attached to the plate 5 hours post-seeding. In 
addition, the mesenchymal stromal cells from the nasal mucosa not only attached slower to the 
bottom of the culture plate, they also proliferated slower when compared to the other cells. 
 
4.5.4 Replication capabilities of the immortalized mesenchymal stromal cells  
 
Cell cycle analysis was performed to distinguish immortalized mesenchymal stromal cells in 
different phases of the cell cycle for determining their replicative capabilities. It was observed that 
the majority of the cells were at the quiescent/preparatory stage (G0/G1 phase) of the cell cycle. 





mucosa than from the other tissues. The percentages of nasal mucosa, lung, spleen, lymph node and 
red bone marrow mesenchymal stromal cells that were at the DNA synthesis stage (S phase) of the 
cell cycle were 8±0.5%, 7±0.4%, 8±0.6%, 8±0.6%, 4±0.3%, respectively; 6±1%, 8±0.5%, 8±0.1%, 
7±0.6%, 8±0.06% were at the DNA duplication and cell division stage (G2/M phase), respectively 
(Fig 4A, B).  
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Fig 4. Cell cycle analysis of immortalized mesenchymal stromal cells. Most cells of the five mesenchymal cells were 
at the G0/G1 phase of cell cycle (A). The data are represented as mean of three independent experiments (B). 
 
4.5.5 Immortalized mesenchymal stromal cells retain the ability to differentiate to osteo-, 
chondro- and adipocytes 
 
Five days after incubation with osteogenic differentiation medium, the immortalized mesenchymal 


































































organic compound which binds specifically to calcium ions). Deposits of calcium (red) were 
observed with the five different mesenchymal stromal cell lines (Fig 5). 
100% of the immortalized mesenchymal stromal cells from nasal mucosa, spleen, lymph nodes and 
red bone marrow and 70-80% of the lung-derived immortalized mesenchymal stromal cells 
differentiated into osteocytes. After culturing the immortalized mesenchymal stromal cells in 
adipogenic differentiation medium for 5 days, adipogenesis was demonstrated by staining with oil 
red O solution. Lipid droplets were observed on all differentiated mesenchymal stromal cells (Fig 
5). To confirm the differentiation of mesenchymal stromal cells derived from nasal mucosa, lungs, 
lymph nodes, spleen and red bone marrow into chondrocytes, immortalized mesenchymal stromal 
cells were incubated in chondrocyte differentiation medium. After 7 days, the mesenchymal stromal 
cells showed a dark-blue coloration upon alcian blue staining, indicating that the mesenchymal 


















Fig 5. In vitro differentiation of immortalized mesenchymal stromal cells. Immortalized mesenchymal cells 
differentiation into chondrocytes (see dark-blue color-chondrocytes), osteoclast (see red color-calcium deposit), and 
adipocytes (see lipid droplets in the cells) confirmed by staining with alcian blue, alizarin red and oil red, respectively. 
Scale bar ꞊꞊ 10 μm.  





























































50-60% of the red bone marrow-derived immortalized mesenchymal stromal cells, 70-80% of the 
nasal mucosa and lymph node-derived immortalized mesenchymal stromal cells and 100% of lung 
and spleen-derived mesenchymal cells differentiated into chondrocytes after 1 week of culture in 
chondrogenic differentiation medium. 
 
4.5.6 Viability of immortalized mesenchymal stromal cells cultured in cytokine-free serum 
 
To develop a culture system for accessing the immunomodulatory effect of the mesenchymal cells 
without interference of cytokines present in the fetal calf serum, immortalized mesenchymal stromal 
cells were cultured in DMEM supplemented with cytokine-free serum for one week and their 
viability was determined afterwards. Flow cytometry data analysis indicated 83±1%, 91±8%, 
89±12%, 84±2% and 94±3% viable cells in cultures of mesenchymal stromal cells from nasal 









Fig 6. Expansion of immortalized mesenchymal stromal cells in medium supplemented with cytokine-free serum. 
Viability of immortalized mesenchymal cells derived from nasal mucosa, lungs, spleen, lymph nodes and bone marrow 
cultured in DMEM supplemented with cytokine-free serum. The data are represent as mean +/- SD of three independent 
experiments. 
4.5.7 Immortalized mesenchymal stromal cells induced the expression of siglec-1 in co-
cultured blood monocytes 
 
Nasal mucosa, lung, spleen, lymph node and bone marrow derived immortalized mesenchymal 





Fig 7. Co-culturing blood monocytic cells with immortalized mesenchymal stromal cells triggers siglec-1 
expression. The red staining reveals siglec-1 expression. Percentages in the fluorescent images were for single 
experiments, while those in the graph were mean percentages of three independent experiments. Each point represents 








An increase in the percentages of siglec-1 positive monocytes and its expression from 24 hours to 
one week after the start of co-culture was observed: from 16% to 93% (nasal mucosa-derived 
mesenchymal stromal cells), from 6% to 73% (lung-derived mesenchymal stromal cells), from 17% 
to 55% (spleen-derived mesenchymal stromal cells), from 18% to 68% (lymph node-derived 
mesenchymal stromal cells) and from 11% to 66% (red bone marrow derived-mesenchymal stromal 
cells). Siglec-1 was not expressed in monocytic cells cultured without mesenchymal stromal cells 
(Fig 7). In contrast to siglec-1, the results indicated some variations in the expression of CD163 
especially at 24 h after the start of the co-culture. There was a decrease in the percentages of CD163+ 
blood monocytic cells co-cultured with immortalized spleen, lymph nodes and bone marrow 
derived-mesenchymal stromal cells when compared with pure blood monocytes (in the absence of 
mesenchymal stromal cells). Also at 48 h and one week after the start of co-culture a slight decrease 
in the percentages of CD163+ cells was observed when compared with monocytes cultured without 
mesenchymal stromal cells. Similarly, the fluorescence intensity of CD163+ in blood monocytic 
cells co-cultured with mesenchymal cells decreased when compared with monocytes cultured 
without mesenchymal cells. Variation among the three individual pigs used in this study was 



































Fig 8. Co-culturing blood monocytic cells with immortalized mesenchymal stromal cells. The red staining reveals 
CD163 expression. Percentages in the fluorescent images were for single experiments, while those in the graph were 
mean percentages of three independent experiments. Each point represents an individual pig (three independent 








Mesenchymal stromal cells have already been isolated and characterized from different tissues and 
organs of humans, mice and other animals (da Silver et al., 2006, DeBari et al., 2001; Int´Anker et 
al., 2003; Yang et al., 2003). Isolated mesenchymal stromal cells undergo senescence or apoptosis 
by passaging in in vitro cultures. To be able to expand the cells continuously and generate large 
amounts of mesenchymal cells for long-term research, such as tissue engineering, mesenchymal 
stromal cells were immortalized using a wide range of methods (Abdallah et al., 2006; Lee et al., 
2013). In this study, mesenchymal stromal cells derived from nasal mucosa, lungs, spleen, lymph 
nodes and red bone marrow were successfully isolated, immortalized and characterized. We 
demonstrated the ability of these cells to trigger the expression of siglec-1 by blood monocytic cells 
during their co-culture. Results from this work indicated that mesenchymal cells derived from nasal 
mucosa, lungs, spleen, lymph nodes and red bone marrow expressed the mesenchymal stromal cell 
specific markers CD105, CD90 and CD44, but were negative for CD16 and CD11b. Similar results 
were reported by many research groups for human, mice and porcine mesenchymal stromal cells 
(Amaral et al., 2014, Sung et al., 2008; Casado et al., 2012). The five immortalized mesenchymal 
stromal cell lines continued to grow without undergoing senescence after several passages, while 
the primary mesenchymal stromal cells died after some passages. It was reported that human and 
guinea pig primary mesenchymal stromal cell growth and proliferation rates decreased gradually 
after a few passages (Kang et al., 2004). A growth curve analysis demonstrated that the five 
immortalized mesenchymal stromal cell lines had a similar growth pattern, with red bone marrow-
derived mesenchymal stromal cells being the strongest grower and nasal mucosa-derived 
mesenchymal stromal cells being the slowest grower. This was confirmed by cell cycle analysis 
which showed that a substantial percentage of immortalized nasal mucosa derived mesenchymal 
stromal cells were in the sub-G phase, which are considered to be dead cells. In this study, the 
immortalized mesenchymal stromal cells could be differentiated into osteocytes, chondrocytes and 
adipocytes (Darimont et al., 2003, Hung et al., 2010, Okomoto et al., 2002). Interestingly, all five 
mesenchymal stromal cell types required only 4 days to differentiate into osteocytes and adipocytes 
and 7 days to differentiate into chondrocytes after initial culture in osteogenic, adipogenic and 




cultures established in this work need only a short time to differentiate into osteoclasts, adipocytes 
and chondrocytes. Indeed, many reports mentioned that mesenchymal stromal cells of humans and 
mice origin need two to three weeks to differentiate into osteocytes, adipocytes and chondrocytes 
after initial exposure to specific differentiation medium (Khatri et al., 2015).  
Siglec-1, also called sialoadhesin or CD169, is a member of the sialic acid binding immunoglobulin-
like lectin family found to be expressed on differentiated tissue macrophages in lungs, liver, colon, 
spleen, lymph nodes and bone marrow (Vanderheijden et al., 2003; Hua et al., 1998). Siglec-1 has 
been reported to function in cell-cell interactions and in receptor-dependent internalization 
processes such as the internalization of porcine reproductive and respiratory syndrome virus 
(PRRSV) (Tse et al., 1998). It is not expressed on porcine monocytes.  
The majority of research groups that work with human, mice and other animal models mesenchymal 
stromal cells use T-lymphocytes, B-lymphocytes, NK cells and dendritic cells to assess the 
immunomodulatory effect of mesenchymal cells with little emphasis given to cells of the 
monocyte/macrophage lineage (Salmani et al., 2008; English et al., 2008). Previous findings 
indicated functional interactions between macrophages and mesenchymal stromal cells leading to 
phenotypic changes in the macrophages (Anton et al., 2012). In the present study, the effect of 
mesenchymal cells on the differentiation of blood monocytes was examined. SV40LT immortalized 
mesenchymal stromal cells from nasal mucosa, lungs, spleen, lymph nodes and red bone marrow 
triggered the expression of the macrophage differentiation marker siglec-1 in co-cultured blood 
monocytic cells. A higher percentage of siglec-1+ monocytic cells was observed when co-cultured 




In conclusion, SV40LT immortalized mesenchymal stromal cells derived from nasal mucosa, lungs, 
spleen, lymph nodes and red bone marrow were successfully established and differentiated into 
osteocytes, chondrocytes and adipocytes. Moreover, they were able to activate the expression of 
siglec-1 on blood monocytes. This method can now be used to establish continuous mesenchymal 





be used to generate large amounts of siglec-1+ macrophages in a few days in a simple and affordable 
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Mesenchymal stromal cells are multipotent, non-hematopoietic cells found in the stroma of bone 
marrow and in many other tissues. They are capable of differentiating into many cell types including 
osteoblasts, chondrocytes and adipocytes. Porcine reproductive and respiratory syndrome virus has 
a restricted tropism for cells of the monocytic lineage. Siglec-1 (sialoadhesin) is a crucial receptor 
involved in attachment to and internalization of porcine reproductive and respiratory syndrome virus 
(PRRSV) into macrophages. In the previous chapter we showed that co-culturing blood monocytes 
with immortalized mesenchymal stromal cells derived from nasal mucosa, lungs, spleen, lymph 
nodes and red bone marrow triggers the expression of siglec-1 in blood monocytes. The present 
work aimed to examine if the latter mesenchymal stromal cells increase the susceptibility of co-
cultured blood monocytes for PRRSV infection. Immortalized mesenchymal stromal cells, 
inoculated with PRRSV (LV (subtype 1) and Lena (subtype 3)), were found to be resistant to 
PRRSV. When blood monocytes co-cultured with immortalized mesenchymal stromal cells were 
inoculated with PRRSV (LV (subtype 1) and Lena (subtype 3)) and analyzed by confocal 
microscopy at 12 hours post-inoculation, up to 7±1%, 18±0.9% and 86±1% of LV-inoculated cells 
and 33±1%, 45±3% and 88±2% of Lena-inoculated cells were found to be infected at 24 h, 48 h and 
72 h of co-cultivation, respectively. In contrast, only 0.8±2-2±1.5% LV-inoculated cells and 1±0.5-
3±1% Lena-inoculated cells were observed to be infected in monocyte cultures at 24, 48 and 72 h 
cultivation and 12 hpi (hours post-inoculation). In conclusion, immortalized mesenchymal stromal 
cells isolated from nasal mucosa, lungs, spleen, lymph nodes and bone marrow were able to enhance 












Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the most important viral 
diseases that causes huge economic losses to the pig industry worldwide (Snijder et al., 1998). 
PRRSV causes reproductive disorders such as late gestation and stillbirth in sows and changes in 
sperm quality in boars. Porcine reproductive and respiratory syndrome virus (PRRSV) was first 
reported in America and later in Europe where the infectious agent causing the syndrome was 
isolated. Two major viral types with strong genetic and antigenic differences were identified: type 
1 (European; prototype Lelystad-LV) and type 2 (American; prototype VR2332) (Mardassi et al., 
1994). The target cells for PRRSV in vivo are differentiated macrophages and porcine primary 
alveolar macrophages are used to propagate the virus in vitro.  Sialoadhesin or siglec-1 is expressed 
only on macrophages and plays an important role in the attachment and internalization of PRRSV 
into the host cells. Mesenchymal stem cells are multipotent cells capable of differentiating into many 
cell types, which include osteoblasts, chondrocytes and adipocytes (Pittenger et al., 1999; Gerson 
et al., 1999). They were first identified in red bone marrow cell cultures; later their isolation from 
various sources was reported. Pre-clinical studies using animal models indicated the therapeutic 
potential of mesenchymal cells in treating several pathologies such as cardio-vascular diseases, 
diabetes and autoimmune diseases, as well as in regenerative medicine (Singla et al., 2010; Lin et 
al., 2009; Gonzalez-Rey et al., 2010; Trottier et al., 2008). Mesenchymal stromal cell 
immunomodulatory properties include modulating different immune cells by secreting anti-
inflammatory factors such as TGF-β (Di Nicola et al., 2002) which can inhibit T-cell proliferation. 
Mesenchymal stromal cells have also been reported to regulate the differentiation and function of 
dendritic cells (Nauta et al., 2006). Furthermore, it has been observed that co-culturing macrophages 
with mesenchymal stromal cells increases their IL-10 expression and decreases their TNF-α and IL-
12 expression (Kim et al., 2009). Human mesenchymal cells enhance the replication of 
cytomegalovirus and H1N1 influenza virus by inhibiting the secretion of IFN-γ and proliferation of 
T-cells responsible for the control of these viruses in in vitro studies.  
There is a general need for long-term mesenchymal stromal cell cultures for in vitro research, which 
is hindered by the short life span of primary cells in in vitro cultures (Wagner et al., 2008; Bork et 





(Stewart et al., 2002; 2006). The widely used method to immortalize primary cells is the introduction 
of viral genes, such as the gene of simian virus 40 encoding large T antigen or the gene encoding a 
telomerase (Jha et al., 1998; Kirchhoff et al., 2004).  
In the present study, we investigated the effect of immortalized mesenchymal stromal cells from 
porcine nasal mucosa, lungs, spleen, lymph nodes and bone marrow on the susceptibility of blood 
monocytes to PRRSV. 
 
5.3 Material and methods 
 
5.3.1 Cell isolation and characterization 
 
Isolation, immortalization and characterization of mesenchymal cells derived from nasal mucosa, 
lungs, spleen, lymph nodes and red bone marrow were fully described in a previous chapters (Garba 
et al., 2017a and Garba et al., 2017b). Also the isolation and co-cultures of blood monocytes with 
the immortalized mesenchymal stromal cells derived from nasal mucosa, lungs, spleen, lymph nodes 




The PRRSV strains used in this study include the 13th passage of the European subtype 1 Lelystad 
virus which is a kind gift of G. Wensvoort (Institute of Animal Science and Health, the Netherlands) 
and the 3rd passage of the European subtype 3 (Lena). Both the Lelystad and Lena strains were 
propagated on porcine alveolar macrophages (PAM). Supernatant from the cell cultures was 
harvested and centrifuged at 13 000 x g for 10 min. and filtered through a 0.45 µm cell strainer to 
remove cellular debris. The virus was diluted in serum-free medium to a final titer of 105.5 tissue 
culture infectious dose with 50% end point (TCID50)/mL. Subsequently, virus was stored at -70°C 







5.3.3 Virus inoculation of immortalized mesenchymal stromal cells 
 
Before proceeding with the inoculation of co-cultures, immortalized mesenchymal stromal cells 
from all the five tissues were inoculated with 250 µl of PRRSV strain at a titer of 105.5 TCID50 /mL 
for 1 h at 37°C 5% CO2.  Next, the virus suspension was removed from the cells and fresh medium 
was added to the cells and further incubated. Samples were collected at 24, 48 and 72 hpi. 
 
5.3.4 Virus inoculation of immortalized mesenchymal stromal cell-blood monocyte co-cultures 
 
Twenty-four, 48 and 72 h after the initial co-culture of mesenchymal stromal cells with blood 
monocytes, the cells were inoculated with 250 µl of PRRSV strain at a titer of 105.5 TCID50 /mL for 
1 h at 37°C 5% CO2.  Next, the virus suspension was removed from the cells and fresh medium was 
added to the cells and further incubated. Sample collections were performed at 12 hpi. Monocytes 
that were not co-cultured were inoculated in the same way at 24, 48 and 72 h of culture and collected 
12 h later. 
 
5.3.5 Immunofluorescence staining and confocal microscopy 
 
To identify and quantify different PRRSV infected cells in nasal mucosa, lungs, spleen, lymph nodes 
and red bone marrow derived immortalized mesenchymal stromal cell-blood monocyte co-cultures, 
a double immunofluorescence staining was performed. The co-cultures were washed two times with 
PBS and fixed with 4% paraformaldehyde at room temperature followed by permeabilization with 
Triton X-100 for 2 min at room temperature. After two times washing, cells were incubated with 
monoclonal antibodies against porcine sialoadhesin (13E2, IgG2a, 1:200) and mAbs against N-
protein of PRRSV (41D3, IgG1, 1:5) for 1 h at 37°C. Subsequently, the cells were washed two times 
with PBS and further incubated with secondary antibodies Alexa Fluor 488-IgG2a and Alexa Fluor 
594-IgG1 for 1 h at 37°C. Nuclei of the cells were stained with Hoechst 33342. Subsequently, the 
cells were washed two times with PBS. To demonstrate the specificity of the primary antibodies 
used, isotype-matched control monoclonal antibodies against gD of PRV (IgG1, 13D12) and 1C11 
against gB of PrV (IgG2a) were used (Nauwynck et al., 1995). The cells were rinsed with PBS and 





and PRRSV-positive cells were quantified by counting a total of 500 cells per slide using confocal 
microscopy (Leica Microsystem DMRBE, Wetzlar, Germany).  
 
5.4 Statistical analysis 
 
Two-way Anova was used to calculate the statistical significance (P<0.05) of the difference between 
the number of Lena- and LV-infected cells in blood monocytes co-cultured with mesenchymal 
stromal cells derived from nasal mucosa, lungs, spleen, lymph nodes and bone marrow and in 
monocytes without mesenchymal stromal cells. P values equal to or lower than 0.05 were regarded 




Two hours after the addition of the immortalized mesenchymal stromal cells to the monocytic 
cultures, they started to attach to the bottom of the culture plates and by 24 h post-seeding all the 
cells were already attached and spread, forming a semi-monolayer while the monocytic cells 
remained firmly attached to the culture plate. 
To confirm the non-permissiveness of mesenchymal cells to PRRSV, the cells were inoculated with 
the virus using the same titers used to inoculate the co-cultures. Immortalized mesenchymal stromal 
cells from nasal mucosa, lungs, spleen, lymph node and red bone marrow were not infected with 
PRRSV.  
The presence of PRRSV infected cells in monocytes inoculated with PRRSV at 0, 24, 48 and 72 
post-seeding and at 12 hours post inoculation was determined by immunofluorescence stainings and 
confocal microscopy. At 0 hours post inoculation, Lena or LV-infected cells were not detected in 
blood monocytes co-cultured with immortalized mesenchymal stromal cells derived from nasal 







At 24, 48 and 72 h after the co-culture of blood monocytes with mesenchymal stromal cells of 
different origin and 12 h post LV inoculation, 15-25%, 40-50%, 88-92% of the blood monocytes 
was Sn+ and 5-7%, 30-33%, 72-84% of monocytes was PRRSV+, 75-80%, 88-90, 91-98% of the 
Sn+ cells was PRRSV+ and 1-5%, 0.6-3%, 0.3-1.2% of the Sn- cells were PRRSV+. In LV-inoculated 
monocytes cultured without mesenchymal cells, viral infected cells were not detected at 0 hpi. At 
24, 48 and 72 h of cultivation and 12 hpi with LV, 0.8%, 1.5% and 3% respectively, were observed 






Fig 1. LV infection of pure blood monocytes or blood monocytes co-cultured with immortalized mesenchymal 
stromal cells from nasal mucosa, lungs, spleen, lymph nodes and bone marrow. The co-cultures were stained for 
PRRSV N-protein (red) and Sn (green) to quantify and identify (Sn+/-) PRRSV infected blood monocytes. Nuclei were 
counterstained with Hoechst. Scale bar = 10 µm. The Sn+/- PRRSV infected/non-infected blood monocytes were 
determined by counting a total of 500 cells per slide using fluorescence microscopy. The data are represented as mean 
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At 24, 48 and 72 h after the co-culture of blood monocytes with mesenchymal stromal cells of 
different origin and 12 h post Lena inoculation, 16-27%, 39-54%, 77-88% of the blood monocytes 
was Sn+ and 10-18%, 29-45% 73-88% of the monocytes was PRRSV+; 92-95%, 88-90, 93-99% of 
the Sn+ cells was PRRSV+ and 1-3%, 0.6-1%, 0.0-1-0.2% of the Sn- cells was PRRSV+. In Lena-
inoculated monocytes cultured without mesenchymal stromal cells, viral infected cells were not 
detected at 0 hpi. At 24, 48 and 72 h of cultivation and 12 hpi with Lena, 2%, 2.9% and 6% 
respectively, were PRRSV+; and all were Sn-  (Fig 2). Based on the work we performed with Lena 
and LV strain of PRRSV in the present thesis, we observed that Lena strain was more virulent than 
LV strain. More cells were observed to be floating in cultures infected with Lena than with LV, 
maybe that was the reason why more Sn+-infected cells were observed in co-cultures infected with 









Fig 2. Lena infection of pure blood monocytes and blood monocytes co-cultured with immortalized mesenchymal 
stromal cells from nasal mucosa, lungs, spleen, lymph nodes and bone marrow. The co-cultures were stained for 
PRRSV N-protein (red) and Sn (green) to quantify and identify (Sn+/-) PRRSV infected blood monocytes. Nuclei were 
counterstained with Hoechst. Scale bar = 10 µm. The Sn+/- PRRSV infected/non-infected blood monocytes were 
determined by counting a total of 500 cells per slide using fluorescence microscopy. The data are represented as mean 
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Both in vivo and in vitro, PRRSV has a very narrow tropism for cells of the monocyte/macrophage 
lineage. The cellular tropism of this virus depends on the presence or absence of certain important 
receptors such as siglec-1, siglec-10 and CD163 (Calvert et al 2007; Delputte et al., 2005; Xie et al., 
2017). PRRSV infects specific differentiated macrophages located in the tonsils, lungs, spleen, 
lymph nodes, liver, thymus, endometrium and placenta. Many researchers indicated that siglec-1 is 
an important cellular receptor used by PRRSV for attachment and entry into macrophages (Calvert 
et al 2007; Delputte et al., 2005). Siglec-10 has recently been identified as an alternative for certain 
strains. Induction of siglec-1 expression in blood monocytes co-cultured with immortalized 
mesenchymal stromal cells derived nasal mucosa, lungs, spleen, lymph nodes and red bone marrow 
was demonstrated in the previous chapter (Garba et al., 2017b), illustrating the ability of 
mesenchymal cells to modulate and trigger the differentiation of immune cells. In the present work, 
we demonstrated that porcine immortalized mesenchymal stromal cells derived from nasal mucosa, 
lungs, spleen, lymph nodes and red bone marrow strongly increased the susceptibility of blood 
monocytes to PRRSV. When fresh blood monocytes are inoculated with PRRSV only a low 
percentage (<0.5%) becomes infected (Delputte et al., 2007).  Upon culturing of blood monocytes 
for a few days this percentage slightly increased but remained below 6% (present study). In the 
present study, the percentage of PRRSV+ blood monocytes was much higher (>73%) when they 
were co-cultured with immortalized mesenchymal stromal cells from nasal mucosa, lungs, spleen, 
lymph nodes and red bone marrow. The PRRSV infection in siglec-1 positive monocytes (>75%) 
was much higher than in siglec-1 negative monocytes (<5%), demonstrating that the PRRSV 
susceptibility coincides with the siglec-1 expression. Although statistically no significant 
differences in the percentages of LV and Lena were found, it was observed that Lena infected more 
monocytes at 24 h and 48 h of co-culture with immortalized mesenchymal stromal cells which may 
be explained by the higher virulence of this strain compared to LV (Karniychuk et al., 2010). Some 
authors also found differences in replication rates of Lena compared to LV in polarized nasal mucosa 
explants (Frydas et al., 2013). The presence of few Sn- PRRSV-infected cells in the co-cultures at 
24 h, 48 h and 72 h after the initial co-culture and 12 hpi is indicative for the use of a sialic acid 
binding receptor other than siglec-1, such as siglec-10 for the viral entry (Xie et al., 2017). The latter 





performed on the intriguing world of sialic acid binding proteins and their role in PRRSV infection. 
In conclusion, immortalized mesenchymal cells derived from nasal mucosa, lungs, spleen, lymph 
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6.1 General discussion 
 
For a long time, adult bone marrow has been described by many research groups as an important 
source of mesenchymal stromal cells (Friedenstein et al., 1968; Haynesworth et al., 1992; Pittenger 
et al., 1999). Bone marrow mesenchymal stromal cells have been reported to provide mechanical 
and physiological support and to create a hematopoietic microenvironment (Caplan et al., 1991). 
Mesenchymal stromal cells have also been found to reside in many other tissues (Wagner el al., 
2005; Covas et al., 2008; da silva et al., 2006; Lennon et al., 2006). They are fibroblast-like cells 
with self-renewing capacity and ability to differentiate into bone, cartilage and fat cells (Caplan et 
al., 1991). Mesenchymal stromal cells possess an immunomodulatory effect by interacting with a 
plethora of immune cells leading to phenotypical changes and functional responses (Le Blank et al., 
2003). More recently, they are considered to have a therapeutic potential, especially in the treatment 
of graft-versus-host diseases (Horwitz et al., 2008; Caplan et al., 2009; Jones et al., 2008; Javazone 
et al., 2004; Le Blanc et al., 2005).   
Porcine reproduction and respiratory syndrome virus is described as a rapidly evolving virus with 
an enormous economic importance for the swine industry all over the world (Dea et al., 1992a; 
Murtaugh et al., 2010). Genetically, two genotypes of porcine reproductive and respiratory 
syndrome virus have been identified: type I and type II (Mardassi et al., 1994). PRRSV may cause 
severe diseases which are characterized by abortion in sows, still- and weak born piglets and is 
associated with the respiratory disease complex in young piglets (Hill et al., 1990). The virus has a 
specific tropism for certain subsets of differentiated macrophages in different tissues. The subsets 
that are targeted depend on the PRRSV variant and is determined by the cellular binding receptors 
which belong to the siglec superfamily. Each siglec is expressed on a certain macrophage subset. 
The surrounding mesenchymal stromal cells are believed to be the driving force behind the siglec 
expression. 
Differences in the immunomodulatory effect between mesenchymal stromal cells from different 
tissues have been recorded (Park et al., 2009; Kyurkchiev et al., 2013; Elman et al., 2014). Research 
groups working with human and murine mesenchymal stromal cells have a restricted access to 
tissues for isolating mesenchymal cells from different organs or tissues for comparing their 




restrictions to obtain large amounts of tissues from mice and human, respectively. Establishing 
mesenchymal cell lines from tissues of pigs, an animal closer to man both anatomically and 
physiologically than mice, will contribute to a remarkable achievement in obtaining a better 
understanding in the potential of tissue-specific therapeutic applications of mesenchymal stromal 
cells (Kobayashi et al., 2012). Differences in growth rates and induction of monocyte differentiation 
between immortalized mesenchymal stromal cells isolated from nasal mucosa, lungs, spleen, lymph 
nodes and bone marrow may help in understanding the immunomodulatory properties of 
mesenchymal stromal cells in specific tissues and therefore assist in choosing the best mesenchymal 
cells for studying diseases and malfunctions with regard to a particular tissue. Mesenchymal stromal 
cells have self-renewal capabilities but no telomerase activities (Kolquist el al 1998). Continuous 
passaging of mesenchymal stromal cells in in vitro cultures leads to accumulation of reactive oxygen 
species and other cytotoxic agents and subsequent DNA damage and telomere shortening. The latter 
in turn triggers aging (senescence) and apoptosis of the cells. For long-term in vitro experiments 
with mesenchymal cells such as for tissue engineering, immune modulation and infection 
experiments, large amounts of mesenchymal cells are needed. For the generation of macrophages 
by co-culturing with mesenchymal cells for studying PRRSV replication kinetics, mesenchymal 
cells isolated from nasal mucosa, lungs, spleen, lymph nodes and red bone marrow were successfully 
immortalized by transducing the cells with the gene encoding the SV40LT antigen. As the presence 
of non-mesenchymal cells such as epithelial, endothelial and mononuclear cells in mesenchymal 
stromal cell cultures may interfere with the analysis of the obtained results, they should be absent 
in the mesenchymal stromal cell cultures. Contamination of mesenchymal cells with epithelial, 
endothelial cells and mononuclear cells was absent in the mesenchymal stromal cell lines generated 
in this PhD thesis. For decades, human mesenchymal stromal cells have been used by many 
researchers to maintain the proliferation of viable monoblasts without inducing their differentiation 
in long-term in vitro co-cultures (Ito et al., 2014). For example, MS5 and HS27 stromal cell lines 
have been used to maintain viable monoblasts in stromal co-cultures (Klco et al., 2013; van Gosliga 
et al., 2007). Adding a growth factor, such as IL-3, in combination with stromal cells led to the 
differentiation of the blast cells during the long-term culture (Ito et al., 2014). This showed that the 
use of cytokines alone or in combination with mesenchymal cell-progenitor cell co-cultures can 
promote their differentiation and change their phenotypic properties. Cell-cell contact is crucial in 





mesenchymal cells (Ito et al., 2014). Many research groups obtained monoblasts, macrophages and 
dendritic cells via cytokine stimulation during in vitro cultures of monocytes. For example, culturing 
bone marrow cells isolated from pig sternum in growth medium supplemented with recombinant 
porcine GM-CSF alone or in combination with recombinant porcine rpTNF-α for 8 days induces 
the differentiation of these cells to dendritic cells (DC) (Carrasco et al., 2001). Generation of bone 
marrow derived macrophages from bone marrow cells was also successful in the presence of L929-
conditioned medium (Hou et al., 2012), rpGM-CSF and rpIL-4 (Chang et al., 2008) and GM-CSF 
(Fraile et al., 2012). Cells having similar morphological and functional characteristics as 
macrophages can be generated by culturing pig bone marrow cells in medium supplemented with 
horse serum and L929-cell-conditioned medium (Hou et al., 2012). In the present thesis, we were 
able to maintain hematopoietic cells and differentiate them towards macrophages and CD4+ and 
CD8+ cells using only mesenchymal stromal cells without cytokines. In agreement with previous 
studies performed on bone marrow and peripheral blood mononuclear cells (PBMC) cultured in the 
presence of recombinant human colony-stimulating factor-1 (rhCSF1), our results showed an 
increase in size (forward scatter) and granularity (side scatter) of hematopoietic cells co-cultured 
with immortalized mesenchymal stromal cells. Monocyte/macrophage markers CD14, CD172a, 
CD163 and CD169 and lymphocyte markers CD4 and CD8 were used to analyze the hematopoietic 
cells during their differentiation. This technology was later used to generate siglec-1 expressing 
macrophages from blood monocytes for studying the PRRSV kinetics and replication by the use of 
co-cultures of monocytes with immortalized mesenchymal stromal cells as driving force. Although 
many cell lines, such as MARC-145 derived from African green monkey (Kim et al., 1993) and 
porcine kidney epithelial cell (PK-15) expressing the binding and internalization receptors (siglec-
1 or siglec-10) together with the disassembly mediator CD163 (Delrue et al., 2010, Xie et al., 2017), 
have been used for propagating PRRSV (Lee et al 2010; Weingartl et al., 2002; Kapetanovic et al., 
2012). In this context, it is important to find a suitable relevant in vitro culture system for generating 
macrophages to study host-pathogen interactions in order to unravel the many enigmas in the 
PRRSV pathogenesis. Immortalized mesenchymal stromal cells derived from primary 
mesenchymal stromal cells from nasal mucosa, lungs, spleen, lymph nodes and bone marrow were 
co-cultured with blood-derived monocytes for one week in a simple culture system containing 
DMEM supplemented with fetal calf serum without the addition of cytokines. The blood monocytes 




stromal cells to generate siglec-1 expressing macrophages from siglec-1 negative blood monocytes 
is one of the most interesting findings of this work. Siglec-1 becomes expressed in differentiated 
macrophages which has been suggested to function in regulating immune responses and in receptor 
mediated binding and internalization of PRRSV (Oetke et al., 2006; van den Berg et al., 1992). 
Siglec-1 expression in differentiated macrophages residing in tissues such as nasal mucosa, lungs, 
lymph nodes, spleen and bone marrow and our current findings on induction of this marker on blood 
monocytes by mesenchymal stromal cells derived from nasal mucosa, lungs, spleen, lymph nodes 
and bone marrow indicates that mesenchymal stromal cells may be involved either directly or 
indirectly in the pathogenesis of PRRSV in vivo. In the present thesis, a high percentage of siglec-1 
was induced on hematopoietic cells by immortalized bone marrow-derived mesenchymal stromal 
cells three weeks after the initial co-culture and on blood-derived monocytes co-cultured with 
immortalized mesenchymal stromal cells from nasal mucosa, lungs, spleen, lymph node and red 
bone marrow. In contrast to high percentages of siglec-1 positive cells obtained during our co-
cultures, cytokines such as type I or type II IFN, which has been used by many other research groups, 
induced an expression of siglec-1 in a low number of peripheral mononuclear cells and different 
subsets of macrophages isolated from humans (York et al., 2007; Rampel et al., 2008), pigs 
(Delputte et al., 2007) and mice (Chen et al., 2012). The strong immunomodulatory effects of 
mesenchymal stromal cells and their ability to interact with immune cells may play a role in 
increasing the susceptibility of co-cultured blood monocytes to PRRSV infection.  
The Sn- PRRSV-infected monocytes in co-cultures and in monocytes cultured without mesenchymal 
stromal cells may be indicative for the presence of minor subsets of monocytes expressing a marker 
involved in PRRSV attachment and internalization other than siglec-1. Porcine siglec-10 (Xie et al., 
2017) has been reported to be expressed on a minor subset of monocytes and PRRSV may use this 
siglec in co-cultures and in monocytes without mesenchymal stromal cells cultures in the present 
study. It is also very well possible that other not yet discovered sialic acid binding molecules may 
be involved. More work should be performed on this type of molecules on the surface of 
macrophages. 
Expression of CD163 in hematopoietic cells and blood monocytes was also investigated in the 
present thesis because it is a crucial marker for studying porcine monocyte and macrophage 
heterogeneity and it is an essential disassembly mediator for PRRSV. The presence of low 





increase in the percentage of these cells in hematopoietic cells co-cultured with immortalized 
mesenchymal stromal cells was observed. Cultivation of red bone marrow hematopoietic cells in 
the presence of immortalized mesenchymal stromal cells triggered their maturation to monocytic 
cells, based on their CD163 expression, size (high side scatter) and macrophage morphology. This 
shows that coculture with mesenchymal cells triggers differentiation of monocytes into 
macrophages. In another experiment in this thesis, it was found that compared to blood monocytes 
co-cultured without mesenchymal stromal cells, no differences in the expression level of CD163 
was observed on blood monocytes with immortalized mesenchymal stromal cells derived from nasal 
mucosa, lungs, spleen, lymph nodes and bone marrow. This is in agreement with the reports that the 
majority of peripheral blood monocytes express CD163 in humans (Sulahian et al., 2000; 
Moniuszko et al., 2006). In the present study, the expression of CD163 alone was totally not 
sufficient for monocytes to become susceptible for PRRSV infection. This demonstrates the need 
for an additional entry mediator, such as siglecs (Oetke et al., 2006; van den Berg et al., 1992; 
Vinson et al., 2006; Xie et al., 2017). In Fig 1, a hypothetical model of siglec-1 expression upon 
contact of blood monocytes with mesenchymal stromal cells during extravasation and their 
increased susceptibility for PRRSV is presented. 
One of the limitations of this thesis was the use of only one simple marker (siglec-1) to confirm the 
differentiation stage of blood monocytes (Gordon et al., 2005; Passlick et al., 1989; Ziegler-
Heitbrock). Human blood monocytes have been divided into three subsets: CD14highD16-, known as 
classical monocytes, CD14+CD16med, intermediate monocytes and CD14-CD16high, non-classical 
monocytes. Porcine monocytes have been divided into two subpopulations based on their expression 
of CD16 and CD163. CD14+CD163+ monocytes are similar to human CD14+CD16+; they both 
express high level of TNF-α (Sanchez et al., 1999). Although the phenotypic characteristics of 
porcine CD169+ macrophages remains ambiguous, murine CD169+ macrophages are further 
characterized as CD11b+, CD11c+, MHC-II+, CD68+ and F4/80+ (Junt et al., 2007). The absence of 
CD169 on blood monocytes has been reported in swine, but recently, a subset of peripheral blood 
monocytes (CX3CR1
+) in humans has been found to express CD169 (Karasawa et al., 2015). 
Recently, in an effort to characterize monocyte differentiation, research was focused on biomedical 
and structural changes. For example, receptors of GM-CSF, FLT3, CXCL12, and CCL18 have been 
shown to be associated with macrophage differentiation (Sanchez-Martin et al., 2011; Schraufstatter 






























Fig 1. Hypothetical model of siglec-1 expression upon contact of blood monocytes with mesenchymal stromal 
cells during extravasation (environmental sensing). Mesenchymal stromal cells in tissues from spleen, lymph nodes, 
lungs and bone marrow, activate extravasating blood monocytes to differentiate and, as a consequence, to express siglec-
1 through cell-cell contact. This makes them susceptible to PRRSV.  
 
Genome-wide gene expression profiles associated with monocyte to macrophage differentiation 
have also been investigated resulting in the identification of several involved pathways and 
differentiation genes (Hashimoto et al., 1999; Suzuki et al., 2000; Li et al., 2007; Martinez et al., 
2006). In the future, it will be interesting to better characterize the transcriptional and phenotypical 
changes in porcine blood monocytes differentiating into macrophages. 
In the present thesis, it was demonstrated that mesenchymal stromal cells isolated from nasal 





transducing primary cells with the gene encoding SV40LT antigen. The technique to generate these 
cell lines from pig tissues can be copied to generate the same cell types from human and other animal 
tissues. Mesenchymal stromal cells can be used for preclinical applications such as tissue 
regeneration. Co-cultures of nasal mucosa, lungs, spleen, lymph node and red bone marrow with 
hematopoietic cells or blood monocytes as established in the present thesis may be used as tissue 
specific models in studying cross-talk between the two cell types involved. The gained knowledge 
may be useful in finding possible treatments/managements of immunological and inflammatory 
disorders such as auto-immune and graft versus host diseases affecting both human and animals. 
The established co-cultures will also be useful in studying host-pathogen interactions for a better 
understanding of the pathogenesis of many diseases caused by viruses and bacteria and will be 
helping in finding effective treatments. Further mesenchymal stromal cells will be useful for the 
generation of large amounts of differentiated macrophages expressing siglec-1 and CD163 starting 
from blood monocytes for the mass production of PRRSV stocks. 
 
 Future perspectives 
 
Although the findings in this present thesis have undoubtedly increased our understanding of the 
biology of mesenchymal stromal cells, their immunomodulatory effect and their ability to support 
the survival of hematopoietic cells and to drive the differentiation of monocytes into siglec-1 
differentiated macrophages, several aspects need further investigation. Cumulative data obtained 
from literature and this thesis indicated the strong immunomodulatory force of mesenchymal 
stromal cells on immune cells such as hematopoietic cells and blood monocytes. Mesenchymal 
stromal cells are known to phenotypically change these cells into CD169, CD163, CD14, CD4 and 
CD8 cells. Data from literature demonstrated that mesenchymal stromal cells, irrespective of their 
tissue origin, can exert an immunomodulatory effect either through cell-cell contact or by secretion 
of cytokines such as IL-10 and/or other soluble factors such as prostaglandin E2 (PGE2). An 
important question that remains to be answered is: what is the precise mechanism used by the 
immortalized mesenchymal stromal cells established in this present thesis to increase the 
differentiation of blood monocytes into siglec-1 expressing macrophages. The molecules (cytokines 
and/or other signaling molecules) produced by these mesenchymal stromal cell lines that are 




be identified and characterized. IL-10, an anti-inflammatory cytokine highly expressed by 
mesenchymal cells (Ben-Ami et al., 2011; Blaber et al., 2012) that has been reported to induced a 
high level expression of CDl63, which is (Philippidis et al., 2004) a cell mediator necessary for 
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Chapter 1 gives a literature review on the characteristics, immunomodulatory effects and stemness 
properties of porcine mesenchymal cells. Mesenchymal stromal cell-immune cell interactions and 
immortalization of mesenchymal stromal cells were also introduced in this chapter. Further, an 
overview on the taxonomy, virion composition, replication cycle and pathogenesis of porcine 
reproductive and respiratory syndrome virus (PRRSV) is given. 
The aims of this thesis are explained in Chapter 2. 
Mesenchymal stromal cells have been successfully isolated from red bone marrow and several other 
tissues. These cells can differentiate into many cell types such as chondrocytes, adipocytes and 
osteocytes. Due to their multi-lineage differentiation capabilities and strong immunomodulatory 
effect on different types of both innate and adaptive immune cells, mesenchymal stromal cells 
received considerable attention from researchers as cells with great therapeutic potential. The anti-
inflammatory and immunomodulatory effects of mesenchymal stromal cells have been explored for 
their potential use in the treatment of diseases such as graft-versus-host disease and diabetes. 
However, keeping mesenchymal stromal cells and their continuous passaging in in vitro cultures for 
a long time is a major challenge because they undergo senescence and die. Therefore, there is an 
urgent need for establishing continuous mesenchymal stromal cell cultures for studying 
mesenchymal stromal cell-immune cell interactions. The development of an in vitro model for co-
culturing immortalized mesenchymal stromal cells with bone marrow- and blood-derived immune 
cells will help to better understand mesenchymal cell-immune cell interactions for therapeutic 
applications and the effect of mesenchymal stromal cells on host-pathogens interactions, such as 
PRRSV replication in monocytes/macrophages, easing the way for finding possible treatments for 
infectious and non-infectious diseases. 
The specific aims of this thesis are: 
 To develop a long-term co-culture system for maintenance and differentiation of 





 To establish mesenchymal stromal cell lines from different tissues of pigs for long-term 
studies such as the differentiation of blood-derived monocytes into siglec-1 expressing 
macrophages. 
 To explore the effect of mesenchymal stromal cells on pathogen-macrophage interactions 
by examining the replication kinetics of porcine reproductive respiratory syndrome virus in 
macrophages co-cultured with immortalized mesenchymal stromal cells. 
In Chapter 3, a successful isolation of mesenchymal stromal cells was achieved by flushing red 
bone marrow with RPMI. Fibroblast-like cells appeared one week after initial cultivation and were 
passaged several times. Immortalization of primary mesenchymal stromal cells using a recombinant 
lentivirus vector containing the sequence encoding SV40LT transforming protein led to the 
establishment of a mesenchymal cell line from red bone marrow. This was confirmed by the 
immunodetection of SV40LT antigens in the mesenchymal stromal cells. Immortalized 
mesenchymal stromal cells were found to be positive for the mesenchymal stromal cell markers 
CD44 and CD55. After the successful establishment of mesenchymal stromal cell cultures, red bone 
marrow hematopoietic cells were isolated for mesenchymal stromal cell-hematopoietic cell co-
cultures. The long-term maintenance of red bone marrow hematopoietic cells on top of 
mesenchymal stromal cells was achieved in DMEM supplemented with 10% fetal calf serum 
without the addition of cytokines. In addition to the 3-fold increase in the number of hematopoietic 
cells, the immortalized mesenchymal stromal cells were successfully used to trigger the 
differentiation of hematopoietic cells towards cells having a similar morphology with 
monocytes/macrophages and lymphocytes.  This was confirmed by evaluating the expression of the 
myelomonocytic markers CD172a, CD14, CD163, CD169 and T-lymphocyte markers CD4 and 
CD8 in hematopoietic cells co-cultured with immortalized mesenchymal stromal cells using flow 
cytometry. Five weeks after co-cultivation with immortalized mesenchymal stromal cells, flow 
cytometry analysis revealed 92±6% viable hematopoietic cells. Three weeks after co-cultivation, 
flow cytometric analysis showed an increased surface expression of CD172a, CD14, CD163, 
CD169, CD4 and CD8 up to 37±0.8%, 40±8%, 41±4%, 24±2%, 19±5% and 23±3% of the 
hematopoietic cells, respectively.  
In Chapter 4, primary mesenchymal cells were isolated from nasal mucosa, lungs, spleen and 
lymph nodes, immortalized and characterized. The obtained immortalized mesenchymal stromal 





revealed that immortalized mesenchymal stromal cells derived from red bone marrow were the 
strongest growers while immortalized mesenchymal stromal cells derived from nasal mucosa were 
the slowest growers. When cell cycle analysis was performed using flow cytometry to distinguish 
immortalized mesenchymal stromal cells in different phases of the cell cycle, the majority of the 
cells were found in the G0/G1 phase of the cell cycle indicating that the five mesenchymal stromal 
cell lines replicated normally.  More nasal mucosa derived mesenchymal stromal cells were found 
to be in the sub-G1 phase of the cell cycle compared with the mesenchymal stromal cells from other 
tissues. Interestingly, immortalization of the mesenchymal stromal cell derived from nasal mucosa, 
lungs, spleen, lymph nodes and red bone marrow did not affect their phenotypic characteristics, 
because they were found to clearly express the mesenchymal stromal cell specific markers CD105, 
CD90 and CD44 in most of the cells (>80%) and CD29 in 29-42% of the cells. The five cell lines 
were negative for the myeloid markers CD16 and CD11b. Stemness properties of the five 
mesenchymal stromal cell lines were not affected by the immortalization processes. This was 
confirmed by incubating the immortalized mesenchymal stromal cells in osteogenic, adipogenic and 
chondrogenic differentiation medium. After staining the cells with alizarin red, oil red O and alcian 
blue staining solutions, calcium deposits, lipid droplets and dark blue cartilage coloration and in the 
cells were observed, confirming the differentiation of the immortalized mesenchymal stromal cells 
into osteoclasts, adipocytes and chondrocytes, respectively. The immortalized mesenchymal 
stromal cells, derived from the five different tissues, were able to trigger the expression of siglec-1 
in blood monocytes upon their co-culture with mesenchymal stromal cells.  
In Chapter 5, the induction of siglec-1 expression in blood monocytes by immortalized 
mesenchymal stromal cells from different tissues was used to investigate the susceptibility of co-
cultured monocytes for PRRSV infection, because siglec-1 functions as a binding and 
internalization receptor. The hypothesis that increased expression of siglec-1 corresponds with an 
increased susceptibility of macrophages to PRRSV was confirmed in this thesis. When immortalized 
mesenchymal stromal cell-blood monocyte co-cultures were inoculated with PRRSV subtype 1 LV 
and subtype 3 Lena at 24 h, 48 h and 72 h after co-cultivation and 12 hours post-inoculation, an 
increase in infection of blood monocytes was observed which corresponded to an increase in siglec-
1 expression. Confocal analysis revealed that most of the Lena and LV-infected monocytes were 




Chapter 6 gives a general explanation on the research data generated in the present thesis. The first 
part of this chapter gives an overview of (i) the past and current findings about the use of 
mesenchymal stromal cells in the biological world and their immunomodulatory effect and of (ii) 
porcine reproductive and respiratory syndrome virus (PRRSV). Next the results obtained in this 
thesis about the ability of immortalized mesenchymal stromal cells to retain their stemness 
properties, and to drive the differentiation of co-cultured hematopoietic cells and blood monocytes 
are discussed. Finally, a hypothetical model is forwarded on how mesenchymal stromal cells 
induces the expression of siglec-1 on blood monocytes making them susceptible for PRRSV. 
Several important conclusions can be drawn from this thesis: 
 Immortalizing mesenchymal stromal cells from different tissues does not affect their 
morphology and phenotypic characteristics. 
  Immortalized mesenchymal stromal cells from different tissues may differentiate into 
osteocytes, chondrocytes and adipocytes. 
 Immortalized mesenchymal stromal cells from different tissues can direct the differentiation 
of red bone marrow hematopoietic cells and blood monocytes into macrophages.  
 Immortalized mesenchymal stromal cells from different tissues can increase the 







                                                    
Samenvatting 
 
In Hoofdstuk 1 wordt een overzicht gegeven van de karakteristieken, immuno-modulatorische 
effecten en stamceleigenschappen van porciene mesenchymale cellen. De interacties van 
mesenchymale cellen met het immuunsysteem en de immortalisatie van mesenchymale cellen 
worden eveneens beschreven in dit hoofdstuk. Vervolgens handelt dit hoofdstuk over de taxonomie, 
de structuur van het virion, de replicatiecyclus en de pathogenese van het porcien reproductief en 
respiratoir syndroom virus (PRRSV).  
In Hoofdstuk 2 worden de doelstellingen van deze thesis toegelicht.  
Mesenchymale cellen kunnen succesvol geïsoleerd worden uit het rode beenmerg en verschillende 
andere weefsels van het varken. Deze cellen zijn in staat te differentiëren tot verschillende celtypes 
zoals chondrocyten, adipocyten en osteocyten. Wegens hun capaciteit om te differentiëren tot 
verschillende celtypes en hun sterk immuno-modulatorische effecten, is er reeds geruime tijd een 
wetenschappelijke interesse in mesenchymale cellen, met het oog op hun potentiële therapeutische 
toepassingen. Zowel de anti-inflammatoire als immuno-modulatorische effecten van mesenchymale 
cellen werden reeds uitvoerig onderzocht voor hun gebruik in de behandeling van afweerreacties 
tegen donorweefsel na transplantatie of diabetes. De korte levensduur van mesenchymale cellen in 
vitro is echter een belangrijke belemmering voor toepassingen. Bijgevolg is er een dringende 
behoefte aan de ontwikkeling van een continue mesenchymale cellijn om de interacties met 
immuuncellen te kunnen onderzoeken. Het opzetten van een in vitro model voor cocultivatie van 
geïmmortaliseerde mesenchymale cellen met cellen afkomstig uit beenmerg en bloed zal ons meer 
inzicht geven in de mesenchymale cel-immuuncel interacties en therapeutische applicaties. Verder 
zal een dergelijk systeem ons toelaten om de rol van mesenchymale cellen in gastheer-pathogeen 
interacties te onderzoeken, zoals PRRSV replicatie in macrofagen, wat een belangrijke stap kan zijn 
in het vinden van mogelijke behandelingen.  
De specifieke doelstellingen van deze thesis zijn:  
- De ontwikkeling van een lange-termijn cocultuur systeem voor de handhaving en 
differentiatie van  hematopoëtische cellen in monocyten/macrofagen, bovenop 




- De ontwikkeling van mesenchymale cellijnen afkomstig van verschillende varkensweefsels 
voor lange-termijn studies zoals de differentiatie van uit het bloed geïsoleerde monocyten in 
siglec-1 expresserende macrofagen.    
- Het onderzoeken van het effect van mesenchymale cellen op PRRSV-macrofaag interacties. 
 
In Hoofdstuk 3 werden mesenchymale cellen succesvol geïsoleerd door flushing van het rode 
beenmerg met RPMI-medium. Fibroblast-achtige cellen konden worden opgemerkt na één week 
cultivatie en deze werden vervolgens meermaals gesubcultiveerd. Daarna, werden primaire 
mesenchymale cellen geïmmortaliseerd ten einde continue mesenchymale cellijnen te generen van 
het rode beenmerg. De transformatie van primaire mesenchymale cellen werd verkregen door 
lentivirale transductie met het simian virus 40 large T (SV40LT) antigen. Succesvolle transformatie 
werd in een volgende stap aangetoond door middel van immunodetectie van dit SV40LT antigen. 
De geïmmortaliseerde mesenchymale cellen brachten de mesenchymale merkers CD44 en CD55 
merkers tot expressie. Na het bekomen van een mesenchymale cellijn van het rode beenmerg werden 
ook de hematopoëtische cellen in het rode beenmerg geïsoleerd voor cocultivatie met de 
mesenchymale cellen. Deze hematopoëtische cellen van het rode beenmerg konden gedurende een 
lange termijn gecultiveerd worden bovenop de mesenchymale cellen in DMEM-medium aangevuld 
met 10% foetaal kalf serum (FKS) en zonder toevoeging van cytokines. Cocultivatie met 
mesenchymale cellen leidde tot een 3-voudige toename van het aantal hematopoëtische cellen. 
Daarnaast, zetten de mesenchymale cellen de hematopoëtische cellen aan tot differentiatie naar een 
celtype met een gelijkaardige morfologie als deze van monocyten/macrofagen. Dit werd eveneens 
bevestigd wanneer de expressie van myelomonocytische merkers CD172a, CD14, CD163, CD169 
en T-lymphocyten merkers CD4 en CD8 werd nagegaan in de hematopoëtische cellen die 
gecocultiveerd werden met de mesenchymale cellen door middel van flowcytometrie. Vijf weken 
na cocultivatie met geïmmortaliseerde mesenchymale cellen kon door middel van flowcytometrie 
een vitaliteit aangetoond worden van 92±6%. Na slechts drie weken cocultivatie werd eveneens een 
toename van de expressie van CD172a, CD14, CD163, CD169, CD4 en CD8 waargenomen tot 
respectievelijk 37±0.8%, 40±8%, 41±4%, 24±2%, 19±5% en  23±3% van de hematopoëtische 
cellen. 
In Hoofdstuk 4 werden primaire mesenchymale cellen uit de nasale mucosa, de long, de milt en 





deze cellen op de differentiatie van immuuncellen bestudeerd. Analyse van de groei toonde aan dat 
geïmmortaliseerde mesenchymale cellen afkomstig van het rode beenmerg het snelst groeiden, in 
tegenstelling tot deze afkomstig van de nasale mucosa die het traagst groeiden. Om 
geïmmortaliseerde mesenchymale cellen in verschillende fasen van de celcyclus te onderscheiden 
werd gebruik gemaakt van flowcytometrie, waarbij de meerderheid van de cellen zich in de G0/G1 
fase van de celcyclus bevond. Dit toonde aan dat de vijf mesenchymale cellijnen op een normale 
manier repliceerden. In vergelijking met de mesenchymale cellen van andere weefsels, bevonden 
relatief meer cellen afgeleid van nasale mucosa zich in de sub-G1 fase van de celcyclus. 
Opmerkelijk werden de fenotypische eigenschappen van de mesenchymale cellen afkomstig van 
nasale mucosa, long, milt, lymfeknopen en rode beenmerg niet beïnvloed door immortalisatie 
aangezien de meeste cellen (>80%) de mesenchymale celspecifieke merkers CD105, CD90 en 
CD44 en 29-42% de mesenchymale celmerker CD29 tot expressie brachten. De vijf cellijnen waren 
negatief voor de myeloïde celmerkers CD16 en CD11b. De stamceleigenschappen van de vijf 
mesenchymale cellijnen werden niet beïnvloed door het immortalisatieproces. Dit werd bevestigd 
door incubatie van de geïmmortaliseerde mesenchymale cellen in osteogeen, adipogeen en 
chondrogeen differentiatiemedium. Na kleuring van de cellen met alizarine rood, oil red O en 
alciaan blauw oplossingen, werden calcium afzettingen, vetdruppels en een donkerblauwe 
kraakbeenkleuring geobserveerd in de cellen, hetgeen de differentiatie van de geïmmortaliseerde 
mesenchymale cellen in respectievelijk osteoclasten, adipocyten en chondrocyten bevestigde. De 
geïmmortaliseerde mesenchymale cellen bekomen uit de vijf verschillende weefsels waren in staat 
om de expressie van siglec-1 in bloedmonocyten te activeren door co-cultivatie. 
In Hoofdstuk 5 werd de inductie van de siglec-1 expressie in bloedmonocyten door 
geïmmortaliseerde mesenchymale cellen van verschillende origine gebruikt om de gevoeligheid van 
gecocultiveerde monocyten voor een PRRSV infectie na te gaan, aangezien siglec-1 fungeert als 
receptor voor binding en internalisatie. De hypothese dat een verhoogde expressie van siglec-1 
gepaard gaat met een verhoogde gevoeligheid van macrofagen voor PRRSV werd bevestigd in deze 
thesis. Wanneer geïmmortaliseerde mesenchymale cel-bloedmonocyt co-culturen geïnoculeerd 
werden met PRRSV subtype 1 LV en subtype 3 Lena  24, 48 en 72 uur na co-cultivatie, werd een 
toegenomen infectie van bloedmonocyten geobserveerd 12 uur post-inoculatie wat overeenkomt 
met een verhoogde siglec-1 expressie. Confocale analyse toonde aan dat het merendeel van de 




In Hoofdstuk 6 werden algemene verklaringen gegeven voor de onderzoeksresultaten uit deze 
thesis. In het eerste deel wordt een overzicht gegeven van (i) eerdere en huidige bevindingen 
aangaande het gebruik van mesenchymale cellen en hun immunomodulatorisch effect en (ii) het 
porcien reproductief en respiratoir syndroom virus (PRRSV). Vervolgens wordt het vermogen van 
geïmmortaliseerde mesenchymale cellen om hun stamcel eigenschappen te behouden en de 
differentiatie van gecocultiveerde hematopoëtische cellen en bloedmonocyten te dirigeren, 
bediscussieerd. Finaal wordt een hypothetisch model besproken over hoe mesenchymale stromale 
cellen de expressie van siglec-1 op bloedmonocyten induceren waardoor ze gevoelig worden voor 
PRRSV-infectie.   
Verschillende belangrijke conclusies kunnen getrokken worden uit deze thesis: 
 Immortalisatie van mesenchymale cellen van verschillende weefsels heeft geen invloed op 
hun morfologische en fenotypische eigenschappen. 
 Geïmmortaliseerde mesenchymale cellen van verschillende weefsels zijn in staat om te 
differentiëren tot osteocyten, chondrocyten en adipocyten. 
 Geïmmortaliseerde mesenchymale cellen van verschillende weefsels kunnen de 
differentiatie van rode beenmerg hematopoëtische cellen en bloedmonocyten sturen in de 
richting van macrofagen. 
 Geïmmortaliseerde mesenchymale cellen van verschillende weefsels kunnen de 
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